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ABSTRACT 
 
The purpose of this research is to quantify the carcinogenic compound safrole in 
the traditional preparation method of making sassafras tea from the root of Sassafras 
albidum. The traditional method investigated was typical of preparation by members of 
the Eastern Band of Cherokee Indians and other Appalachian peoples. Sassafras is a tree 
common to the eastern coast of the United States, especially in the mountainous regions. 
Historically and continuing until today, roots of the tree are used to prepare fragrant teas 
and syrups. These traditional uses can be found across cultures throughout its range. 
Products made from sassafras are banned from the market by the US Food and Drug 
Administration (FDA) due to a carcinogenic compound, safrole, found in the unprocessed 
root. Low levels of safrole are permitted in Europe due to the small concentration found 
in common spices, including nutmeg and cinnamon. However, in sufficient doses, safrole 
causes genotoxicity and cell toxicity, oxidative stress, and liver cancer in laboratory rats 
after ingestion. In this study, traditionally prepared tea and the FDA method of 
eliminating safrole were analyzed using high-performance liquid chromatography. These 
two methods were compared for effectiveness of eliminating or reducing safrole levels. 
The FDA method resulted in little to no safrole content. A smaller amount of safrole was 
present in the traditionally prepared tea compared to agitate samples, used to gauge a 
baseline concentration of safrole present in the root.  Collaborations with the Center for 
Cherokee Plants within the Cherokee community will help us to return the results of the 
research and contribute resources emphasizing the cultural and historical importance of 
Sassafras albidum. 
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CHAPTER ONE 
 
INTRODUCTION 
 
 
Sassafras albidum is a North American species primarily known for the tea made 
from its roots and root bark. Sassafras has been in use for centuries by the Cherokee, 
Chippewa, Creek, Delaware, Iroquois, Seminole, and other Native American tribes 
within the East Coast range of the tree (Moerman 2011; Hamel & Chiltoskey 1975). 
Many people who were raised in the Southeast remember drinking sassafras tea as a 
child, and families in the mountainous regions still make root tea and syrup today. The 
Eastern Band of Cherokee Indians in Western North Carolina is one such community that 
have preserved and passed down the traditional knowledge needed to utilize sassafras. 
The essential oil extracted from the root of sassafras contains 80-90% safrole 
(Carlson & Thompson 1997). Safrole is a phenylpropanoid, a type of aromatic compound 
that most likely accounts for the strong smell associated with the root (Kamdem & Gage 
1995; Rasch 1998). Safrole is found in small quantities in a number of species consumed 
on a daily basis, including cinnamon, ginger, nutmeg, and cocoa (Heikes 1994). On the 
commercial market, sassafras extract was a common ingredient in foodstuffs, cleaning 
products, and cosmetics as a flavoring agent and fragrance. Until 1960, the sale of food 
containing safrole was legal up to 20 ppm (Carlson & Thompson 1997). In 1960, the 
United States Food and Drug Administration (FDA) banned the presence of the 
compound safrole in foodstuff. Experiments had demonstrated the hepatocarcinogenetic 
(liver cancerous) effect of large doses of safrole on laboratory rats (CFR, Sec. 189). It is 
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possible to buy safrole-free extracts of sassafras tea concentrate where the safrole has 
been removed according to processes set by the FDA (CFR, Sec. 172).  
Many studies have demonstrated the carcinogenic effects of high doses of safrole 
on laboratory rats, but all these studies have used pure safrole standard (Jin et al., 2011; 
Liu et al., 1999; Ueng et al., 2005). As of yet, no research has tested the traditionally 
prepared sassafras tea for carcinogenic properties. In fact, no research has investigated 
the potential concentration of safrole in traditionally prepared sassafras tea. This research 
is important because many people, particularly within southeastern mountain 
communities, continue to prepare and consume products made from sassafras.   
The purpose of this study is twofold: first, to quantify the amount of safrole 
present in traditionally prepared sassafras tea. We will do this by running chemical 
analysis of tea samples and samples prepared following FDA guidelines through high 
performance –liquid chromatography (HPLC). The purpose of running both the FDA and 
traditional samples is to quantify the effectiveness of both methods at reducing safrole 
content. The second objective will focus on education and outreach projects, to return the 
results of the chemical analysis to the community, with which we collaborated and 
complete projects that highlight the cultural and historical importance of sassafras. 
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CHAPTER TWO 
LITERATURE REVIEW 
 
Project Proposal 
The topic of this research project was suggested during a meeting with 
community and tribal members connected to traditional agriculture, history, and granting 
agencies of the Eastern Band. They believed researching the toxicity associated with 
sassafras products would be relevant and interesting to members of the tribe, as tea and 
syrup are commonly made and exchanged between Cherokee members. The products 
could eventually contribute to the economy of the Cherokee if the sale of products was 
achieved or desired. The banning of sassafras products on the market has raised concern 
among those that consume sassafras tea, syrup, and other foodstuffs made from Sassafras 
albidum. Although many continue to consume these products, there is a feeling of 
hesitancy and uncertainty in conversation about the use of sassafras. For the present, 
quantifying the concentration of the main carcinogenic compound in sassafras products 
would be meaningful for many who have consumed sassafras their entire lives. With the 
information from these results, consumers could make informed decisions on the personal 
use of sassafras. Though already a culturally important plant, a study on this species 
would support the continued emphasis of sassafras in the culture and honor the traditional 
knowledge associated with its use. 
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Eastern Band of Cherokee Indians 
The Eastern Band of Cherokee Indians (EBCI) of Western North Carolina own 
more than 56,600 acres of land in five counties slightly south and adjacent to the Great 
Smoky Mountains National Park (Lambert 2007). There are approximately 13,000 
enrolled members, about 8,200 of which live on EBCI-owned land called the Qualla 
Boundary (Hall 2006; Lambert 2007). Historically, the Cherokee territory covered about 
25.6 million acres in the mountains of the southeast, primarily on the Savannah, 
Hiwassee, and Tuckasegee rivers, with their principle town, Echota, on the bank of the 
Little Tennessee. The Kituwah settlement, now known as the Kituwah mound, is located 
along the Tuckasegee River near Bryson City, North Carolina and was possibly the 
original capital of the Cherokee (Duncan and Riggs 2003; Hudson 1979). 
Written history about the Cherokee began in 1540 with the exploration of De Soto 
and other Spanish explorers. As the French and Spanish settled along the coast and 
slightly inland in the 1500’s and 1600’s, there was only occasional contact between the 
groups. Some scholars estimate these early settlers brought diseases that killed 95% of 
Native Americans within the first century and a half of European contact (Duncan and 
Riggs 2003). Being on the edge of the territory claimed by early European settlers, the 
Cherokee were caught up in the politics and bloodshed of the Colonial Period, the French 
and Indian War, and the Revolutionary War, as well as the slave trade of several ethnic 
groups. Exploring settlers slowly absorbed the piedmont regions of Cherokee land and 
the tribe became concentrated in the southern Appalachian Mountains (Finger 1984).  
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The “Civilization Policy” of 1789 by the new American government was a 
crossroads for the Cherokee in terms of adapting to European-style schools, government, 
churches and economy. The written language developed by Sequoyah in 1819, which 
may have been a response to these pressures. The Treaty of New Echota of 1835, signed 
without permission of the Cherokee people as a whole, gave all Cherokee land east of the 
Mississippi to the United States. In 1838, the US government forced 17,000 Cherokee to 
territory in Arkansas and Oklahoma on a march now known as the Trail of Tears. About 
one-quarter to one-half of the ill-equipped travelers perished on the march (Finger 1984). 
A group of three to four hundred Cherokee hid in the mountains of Western North 
Carolina to evade capture by US soldiers. They, along with Cherokee that returned to the 
territory, were the foundation for the present day Eastern Band of Cherokee Indians 
(Duncan and Riggs 2003).   
It is important to know this brief history of the Eastern Band when considering the 
contemporary Cherokee Indians and the efforts they have made to reclaim their rights and 
traditional knowledge. Many historians, ethnobotanists, and anthropologists have studied 
and written about the Cherokee, including James Mooney in the 19
th
 century (Mooney 
1992). He was followed by Frans Olbrechts, who worked with the healer Swimmer to 
publish a manuscript in 1932, and then by John Witthoft, who published articles from the 
1940s to 1970s. There have been a number of books written on the ethnobotany of the 
Cherokee in latter half of twentieth century, including authors William Banks (1953), 
Myra Jean Perry (1974), David Cozzo (2004), and Karen C. Hall (2006). The Museum of 
the Cherokee Indian Press publishes the Journal of Cherokee Studies, as well as many 
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books on the history and culture of the tribe with authors like Barbara Duncan, Vernon 
Crowe, and Duane H. King (MCI 2012). 
 Today, tribal members continue their cultural traditions including the lacrosse-like 
stickball game, the Cherokee language, and traditional Cherokee arts and crafts, all of 
which are integrated with contemporary festivals. They cater to tourists through 
managing a casino, interpretive performances of the Trail of Tears, and selling traditional 
arts and crafts. The Cherokee worldview is represented throughout the landscape where 
they live, including street signs written in Cherokee language and the preservation of 
culturally and spiritually important locations like the Kituwah mound. The Cherokee 
language is reinforced through language immersion schools for members. Many families 
continue to pass traditional ecological knowledge of plant uses through generations and 
between members. 
 
Ecology of Sassafras albidum 
Sassafras is a native deciduous tree species of Eastern North America known for 
its brilliant fall color and a distinct fragrance. Leaves are bright to deep green in the 
summer and change to scarlet, orange, or yellow in the autumn. The tree has 
heterophyllic foliage with three leaf shapes: entire, mitten (both right- and left-handed), 
and trilobed, as seen in Figure 2.1. On rich sites in the Smoky Mountains, sassafras is 
typically a medium-sized tree with a straight bole reaching heights of 9 to 18 m (30 to 60 
ft). On the edges of the habitat range sassafras tends to be shrubby. Sassafras is a 
dioecious species whose female plants produce small racemes of yellow flowers in March 
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or April (Griggs 1990). The odor of the root is very distinct; the scent has been described 
as ‘sweetshop’ or spicy (Dugan 2011).  
Sassafras is found along the Atlantic coast (zones 4 to 9) of the United States 
from northern Florida to Canada, and west to Michigan, Illinois, and Arkansas (Cullina 
2002; Rasch 1998). Sassafras is a generalist species, occupying both full sun and partial 
shade sites with a variety of soil types and moistures. The tree can be found in a wide 
range of ecosystems, including many species of pine dominated forests and oak-hickory, 
maple-beech-birch, and aspen-birch forests.  The rapid growth is achieved through a deep 
taproot as well as shallow, laterally growing root system that send up root suckers 
(Griggs 1990). White-tailed deer, woodchucks, black bears, and rabbits all browse the 
leaves during the summer and winter. Many types of birds (wild turkeys, pileated 
woodpeckers, and northern bobwhites) and some small mammals eat the ripe fruit, a 
single-seeded drupe with a high energy value (Sullivan 1993). Those who wish to 
propagate sassafras usually need to stake out the tree for the highly favored drupe (See 
Appendix A for Propagation techniques). Sassafras is an important host plant for many 
species of moths and butterflies, particularly the host-specific spicebush swallowtail 
butterfly (Carter et al., 1999; Sternberg 2004).  
Sassafras is typically considered shade intolerant, though it can adapt to low light 
intensities of an understory with soil pH of around 5 (Bazzaz et al., 1971). S. albidum is 
typically subdominant but can attain dominance by forming thickets on poor soils 
through allelopathic activity, which includes the release of terpenes and 
phenylpropanoids as well as other secondary defense compounds that deter pathogens 
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and herbivores (Bisset 1994; Gant et al., 1975; Sullivan 1993). These adaptations are 
important when considering the chemistry of the allelopathy: the strong presence of 
allelopathic compounds are found throughout the tree but mainly concentrated in the 
roots. Root wood is porous with characteristic pits and oil cells (Bisset 1994). These 
allelopaths include: 2-pinene, 3-phellandrene, eugenol, safrole, citrol, and s-camphor 
(Griggs 1990). The sassafras root cortex contains 6-9% essential oil, which consists of 
the compounds safrole (80-85% of the total oil), safrole camphor (3.25%), 
methoyleugenol (1.1%), tannins (sassafrid), resin, wax, mucilage, sugar, and sitosterol. 
Another one percent of the oil includes pinene, eugenol, apoil, 5-methoxyeugenol, 
elemincine, estragol, and myristicin (Rasch 1998). 
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Figure 2.1: Heterophyllic leaves of Sassafras albidum
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Safrole 
 
Safrole (5-(2-propenyl)-1,3-benzodioxole) is a phenylpropene, part of the 
aromatic phenylpropanoid family. Safrole has a benzene ring flanked on either side by a 
dioxolane ring and a terminal, highly reactive methylene group, as seen in Figure 2.2 
(Wink et al., 2008). Safrole is insoluble in water but mixes readily with chloroform, 
ether, and other non-polar organic solvents (Budavaris 1989; Burdock 1997). Many of the 
aromatic rings that produce smell and taste of plants are derived from the 
phenylpropanoid metabolism through the shikimic acid pathway (Dewick 1997; Wink 
2010). Phenylpropanoids secondary compounds associated with the taste and smell of a 
plant and therefore are used as deterrents against herbivores that shy away from strong 
secondary metabolites. The compounds also protect against ultraviolet radiation, fungi, 
and bacteria, and can act as pollinator attractants (Hahlbrock 1989). Secondary 
compound activity increases in nutrient-poor soils, which is why sassafras, known for its 
ability to inhabit roadsides and abandoned fields, would have high allelopathic and 
defense tendencies in these locations and therefore higher concentrations of associated 
secondary compounds (Ibrahim 2001). 
 Due to its pleasant smell, sassafras oil used to be a common ingredient (up to 20 
ppm) in foodstuffs, cleaning products, and cosmetics as a flavoring agent and fragrance 
(Carlson and Thompson 1997). Then on December 3, 1960, the US FDA banned the 
presence of safrole, oil of sassafras, isosafrole, and dihydrosafrole in food after 
experiments showed a hepatocarcinogenic effect on laboratory rats (CFR, Sec. 189). 
Many common spices, including black pepper, cocoa, mace, nutmeg, cinnamon, tarragon, 
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star anise, fennel, parsley, basil, bay laurel, dill, pimento (allspice), and cloves, contain 
trace amounts of safrole (Heikes 1994; Zhou et al., 2007). Safrole is also detectable in the 
range of 3-5 mg/L (ppm) in soft drinks that use the spices listed above, including the 
well-known beverages Coca-Cola and Pepsi (Choong and Lin 2001). Alcoholic 
beverages contain between 0.15 and 3 mg/L (ppm) (Curró et al., 1987). In a 2001 
document, the European Commission allowed, “1 mg/kg in foodstuffs and beverages, 5 
mg/kg for alcoholic beverages with more than 25% alcohol by volume and 15 mg/kg for 
foods containing mace or nutmeg” for both safrole and isosafrole (Carlson & Thompson 
1997; SCF 2002; SCF 2003). In 2005 the Council of Europe listed safrole as an Active 
Principle 1, or suspected weakly carcinogenic substance; no maximum daily limit can be 
set for these compounds, but they should be set as low as possible. Safrole is currently 
under evaluation by the Council of Europe (CD-P-SP 2005). Sassafras was most likely 
targeted because of its high concentration of safrole compared to other spices, including 
the often cited nutmeg, which has 2.46 % (w/w) compared to sassafras root (89% w/w) 
(Curró et al., 1987).  
Pure safrole oil is still imported to Europe, Japan, and the United States from 
Brazil and countries in the South Pacific. Safrole-rich species in the Cinnamomum and 
Ocotea genera are harvested to be synthesized into piperonyl butoxide, used in pesticides, 
and piperonal, a flavoring and perfume ingredient (Miglierini 2008; Oltramari et al., 
2004). Safrole is also an essential ingredient in the production of the illegal drug MDMA, 
also known as Ecstasy (Rasch 1998). Safrole is designated as a List I Chemical by the 
U.S. Drug Enforcement Administration, implying that the chemical is used in the 
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manufacture of controlled substances as well as having legitimate uses (CFR, Sec. 
1310.02).  
Laboratory Studies 
Safrole is classified as a weak carcinogen in laboratory rodents due to the creation 
of safrole intermediates that form hepatic DNA adducts (Liu et al., 1999). Conventional 
genotoxicity tests, including sister chromatid exchange and micronucleus tests, tested 
positive for in vitro toxicity of safrole, and many in vivo tests of safrole have established 
carcinogenic doses of safrole, both through incorporating safrole into the diet and 
injection (Jin et al., 2011; SCF 2002). Safrole is absorbed passively from the 
gastrointestinal tract, but it is thought that safrole is non-toxic in its unaltered form. 
Rather, safrole must be metabolically activated to be toxic to humans, a fact confirmed by 
neutral or negative results of an Ames test of safrole (Frohne & Pfander 2004; Swanson 
et al., 1979; Wink 2008). Some research has investigated utilizing the toxicity of safrole 
for human advantages, including anticancer drugs, insect fumigants, contact pesticides, 
and anti-fungicides (Casida et al., 1966; Catalán et al., 2010; Huang et al., 1999; Khayyat 
2011; Khayyat & Al-Zahrani 2011; Kim & Park, 2008; Zhao et al., 2005). 
Metabolites of safrole formed in vivo include but are not limited to   
1’-hydroxysafrole (considered the most toxic), dihydrosafrole (p-n-propyl-
methylenedioxybenzene), isosafrole (1-propenyl-3,4-methylenedioxybenzene), and 
eugenol (4-allyl-2-methoxyphenol) (Heikes 1994). As the body attempts to rid itself of 
the non-nutritive lipophilic molecule through the liver, the defense system undergoes a 
phase I reaction to convert the molecule to a nucleophilic substance (Shibamoto et al., 
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Figure 2.2: Chemical Structure of Safrole 
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2009). Metabolic activation of safrole to its carcinogenic derivatives can be simplified 
into four [4] different transformations. The first [1] transformation involves the oxidation 
of the allyl side chain in cytochrome P450 by the enzyme CYP2A6 to form 1’-
hydroxysafrole. This compound can undergo sulfation to form 1’-hydroxysafrole sulfate 
(Daimon et al., 1997/8; de Vries 1997; Jeurissen et al., 2004; Zhou et al., 2007). These 
electrophilic, sulfuric acid esters form safrole-DNA adducts in human hepatoma (HepG2) 
cells and induce cancerous formations (Liu et al., 1999; Miller et al., 1983; Zhou et al., 
2007). Safrole-DNA adducts lead to the induction of sister chromatid exchanges and 
chromosomal aberrations, which lead to mistakes in DNA replications and mutations that 
has the possibility of carcinogenesis, as well as cytotoxicity (Daimon et al., 1997). 
Adducts concentrate in hepatic DNA as the liver is the detoxifier and metabolizer of 
drugs for the body (Nakagawa et al., 2009). 
A second [2] transformation falls within a different pathway to chemical 
carcinogenesis: oxidative stress, which causes faulty incorporation during DNA 
replication. Safrole can undergo cleavage of the dioxolane ring to form hydroxychavicol 
(4-allyl-1,2-dihydroxybenzene), shown in the pivotal Benedetti study to be the major 
urinary metabolite of rodents and humans. The Benedetti et al., study is the only research 
as of yet to test the results of human subjects ingesting safrole (Benedetti et al., 1977; Liu 
et al., 1999). Hydroxychavicol, best known in connection to betel quid chewing, has the 
potential to transform to the reactive elecrophiles ortho-quinone or para-quinone 
methide. These metabolites can further transform to reactive oxygen species that can 
induce oxidative damage. Hydroxychavicol is more toxic than safrole and has been 
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linked to mitochondrial dysfunction (Bolton et al., 1994; Nakagawa et al., 2009). Though, 
unlike DNA-safrole adducts, oxidative stress has been shown to be reversible. The 
damage was repaired within 15 days after safrole was administered, compared to stable 
DNA adducts that have been detected 30 to 140 days after ingestion (Gupta et al., 1993; 
Liu et al., 1999). The damage initiated by hydroxychavicol can also be prevented in vivo 
by antioxidants like vitamin E (Liu et al., 1999). 
The first two transformations are the main metabolic pathways in animals. A third 
[3] transformation involves epoxidation of safrole by the double bond of the propenyl 
group to form safrole-2’,3’-epoxide (de Vries 1997). The fourth [4] transformation is the 
gamma oxidation of the allylic side chain leading to a carboxylic acid, which can 
conjugate with glycine (CSF 2002). The two major safrole-DNA adducts for this 
transformation are N
2
-(trans-isosafrol-3’-yl)2’-deoxyguanosine and N2-(safrole-1’-yl)2’-
deoxyguanosine (Gupta et al., 1993). 
 The effect of safrole on laboratory rats and mice is well documented. Rodents 
given large doses of pure safrole in their diet (via oral gavage, subcutaneous injection, or 
mixed into food) suffered from mortality and a range of liver and kidney damages. 
Physiological aliments included slight impairment such as weight loss, mild anemia, and 
growth retardation. Aliments also included moderate and severe damage, including liver 
tumor masses and nodules, liver enlargement, focal to chronic nephritis in the kidney and 
liver, bile-duct proliferation, fatty metamorphosis, and mortality (Abbott et al., 1961; 
Daimon 1998; Epstein et al., 1970). Genotoxicity assays were positive for sister 
chromatid exchange (SCE), unscheduled DNA synthesis (in cultured rat hepatocytes), 
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chromosomal aberrations, gene mutation, and cell transformation (Howes et al., 1990; 
Ishidate & Sufuni 1985; Mihr et al., 1985; Purchase et al., 1978). Safrole did test neutral 
or negative in an Ames test (Salmonella reverse mutation assay) as mentioned before, as 
well as mouse dominant lethal assay, bone-marrow micronucleus assay, and unscheduled 
DNA synthesis in HeLa cells (Baker & Bonin 1985; Epstein et al., 1972; Gocke et al., 
1981; Martin et al., 1978; Mirsalis et al., 1982). Ingestion of safrole at high doses can 
cause symptoms such as nephritis, unconsciousness, weakness, liver disturbance, CNS 
stimulation, and skin irritation (Wink 2008). Also see Appendix C for complete chart of 
laboratory studies. 
 
Toxicology and Dosage 
 Toxicology research utilizes two models to determine the potency of compounds, 
including qualitative and quantitative methods. Qualitative methods can include 
observations of lesions and clinical signs, while the quantitative model examines the dose 
and exposure levels. The ultimate goal is to determine a structure-activity relationship 
that outlines the biological effects of a substance at physiological and biochemical levels. 
To evaluate a compound for human safety, toxicology studies examine several species of 
laboratory animals (rats, mice, dogs, rabbits, primates) that have similar physiology and 
genetic structure to humans (Reagan-Shaw 2007). Researchers use several dose levels, 
where the higher dose levels are to understand the biochemical mechanisms and a 
maximum amount is established for safe consumption. The mode of ingestion or 
exposure should be considered in clinical tests; for example, feeding laboratory rats the 
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food additive compounds through their diet as opposed to subcutaneous injection or oral 
absorption (Dixon 1976).   
As the 16
th
 century Swiss-German chemist/physician Paracelsus held, ‘Poison is 
in everything, and no thing is without poison. The dosage makes it either a poison or a 
remedy’ (“Paracelsus” 2012). In estimating toxicity and the possibility of carcinogenicity, 
the dose is critical as is the perceived risk. For risk in using food additives in particular, 
no amount of carcinogen is accepted as additions to food are risks than can be avoided 
(Extoxnet 2012).  In terms of dose, dose translation is necessary to compare doses 
between different species, particularly between human and laboratory animals. The use of 
body weight to compare doses between studies has been criticized as it may not 
accurately correlate to volumes of blood and plasma proteins (Dixon 1976). Body surface 
area (BSA) has been shown to associate these parameters, or total blood and plasma 
protein volume, in addition to basal metabolism, renal functions, and oxygen and calorie 
utilization. The equation used by Reagan-Shaw et al. (2007) to translate doses between 
animal species and human:  
Human equivalent dose (mg/kg) = Animal dose (mg/kg) * Animal Km/Human Km 
(Reagan-Shaw et al., 2007). Km values (mg/m
2
) are listed in the paper for several species 
and are based on height-weight measurements. In this thesis, mg/kg bw (body weight) 
refers to mg of compound by body weight of the subject, either human or animal. The 
unit listed as mg/kg refers to mg of a compound in kg of material.  
Another aspect of dosage to consider is the difference in employing high versus 
low dosage. The ‘Virtual Safe Dose’ for human consumption is calculated with a linear 
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model, “which assumes that cancer causation is directly proportional to dose and that 
there are no unique effects of high doses” (Ames & Gold 2000). A dosage margin of 
safety for humans is typically calculated by dividing a lethal dose of the compound for 
laboratory rodents by a factor of 100 (Segelman et al., 1976). An exaggerated high dose 
of a compound, as in experiments to understand the mechanisms of carcinogenicity, can 
cause wounding and death of tissue and cells and chronic cell division of neighboring 
cells. It is possible the resulting cellular necrosis and carcinogenesis is inflated in high 
doses, a point discussed in literature on safrole.  
The Benedetti et al. (1977) study examined the response of rats and mice to 
consumption of safrole in addition to human subjects. Even at the smallest dose of 0.63 
mg/kg bw (body weight), 88% of the safrole was eliminated by the rats within 24 hours. 
The authors point out that when the dose of safrole for the rodents was increased to levels 
common in carcinogen studies (between 500 to 1000 mg/kg bw), safrole rapidly 
accumulated in the liver and kidney, and safrole was not metabolized as quickly and 
therefore eliminated more slowly than rats fed smaller doses. They argue that the toxic 
accumulation associated with these carcinogenic studies was due to this slow metabolism 
of safrole and subsequent tissue absorption was a result of the unrealistic doses. Lower 
doses (or accurate amounts of safrole in food and drinks) would not lead to safrole 
accumulation in tissue muscle (Benedetti et al., 1977). Gupta (1993) found a dose of400 
mg safrole/kg bw for mice to be the point of saturation of detoxification enzymes.  
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Safrole in Food and Spices 
The HERP Index, or Human Exposure/Rodent Potency index lists a daily level of 
safrole ingestion at 1.4 mg/kg bw per day for a 60 kg person from the various safrole-
containing spices like black pepper, star anise, cumin, cinnamon, and ginger root (HERP 
2011). The European Commission estimated the daily intake of consumers (by the 
quantity of safrole added to food by industry) to be 0.3 mg/day, or 0.005 mg/kg bw for a 
60 kg person (SCF 2002). The WHO estimates a daily range of safrole intake as 4 to 569 
μg for Americans and between 0.6 and 879 μg for those in the European Union, based on 
spice content and annual volume consumed by country (WHO 2009). The median toxic 
dose (TD50) of safrole, according to the HERP Index, for mice is 51 mg/kg bw per day 
(HERP 2011). Segelman et al. estimate a dose of 0.66 mg/kg bw may be toxic to man, 
based on a study by Epstein et al. (1970) that found 66 mg/kg bw of safrole administered 
over a 21 day period to be carcinogenic to infant male mice. Studies commonly use a 
margin-of-safety factor of 100 to estimate toxicity, hence the 0.66 mg/kg bw (Segelman 
et al., 1976).  
In the only study found with human subjects, Benedetti et al. (1977) observed the 
effects of human consumption of safrole with two doses (0.163 mg and 1.655 mg). They 
concluded both amounts of safrole were completely eliminated in 24 hours with little 
possibility of safrole accumulating in tissue muscles. In the human subjects, safrole was 
eliminated as small amounts of unchanged safrole and safrole metabolites, specifically 
1,2-dihydroxy-4-allylbenzene, eugenol, and an isomer of eugenol. The metabolites 3’-
hydroxylisosafrole and 1’-hydroxysafrole (the most toxic metabolite) were not detected. 
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The authors suggest the absence of the latter metabolites could also be due to the dose or 
to the differences in metabolism between man and rodent (Benedetti et al., 1977).  
Safrole is present in the flowers of Piper betle, used in the betel quid chewing 
tradition (similar to tobacco dip in the United States) prevalent among the male 
population of Taiwan. Betel quid has been linked to the high rates of oral cancer due to 
the high level (15,000 mg/kg plant material) of safrole present in the flowers, which are 
used in the betel quid mixture. Exposure to safrole in the saliva during chewing is 
estimated between 70 mg/L to 68120 mg/L (or 420 μmol/L) (Chen et al., 1999; Liu et al., 
2000). Research on betel quid chewing in India and Southeast Asia suggested the 
presence of safrole could be causing the high rates of oral cancer and other diseases by 
inhibiting the bactericidal activity and releasing reactive oxygen species (Hung et al., 
2003). A study examining betel quid chewing among pregnant women found that adverse 
pregnancy outcomes, including lower birth weight, stillbirth, fetal malformation, and 
premature delivery, were 2.8 times higher than women who did not chew betel quid 
(Yang et al., 2001). Overall, it is difficult to compare betel quid chewing to consuming 
sassafras tea due to the different paths of ingesting safrole (absorbed through the mouth 
and saliva versus gastrointestinal absorption) and the range of doses. 
 
Previous Studies on Foods Containing Safrole 
A handful of studies have examined sassafras tea. Carlson & Thompson (1997) 
examined several types of herbal products derived from sassafras, including leaves, tea 
concentrate, herbal powder capsules, and tinctures, as well as a ‘sassafras tea’ prepared 
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from instructions from a modern herbal guide. The ‘tea’ made in this study was infused, 
or the tea bag steeped in hot water for thirty minutes as opposed to the traditional method 
of decocting, or boiling, the whole or roughly chopped root. They demonstrated that 
herbal products of sassafras ranged from zero to a miniscule amount of safrole in tea 
made from the leaves, to containing 92.4% safrole in sassafras oils. The ‘tea’ they 
prepared had safrole content ranging from 0.03 to 1.37 mg per gram of powdered root 
material, or only 6.9% to 17.2% of total safrole present in the root (Carlson & Thompson 
1997). There were several differences between the Carlson & Thompson study and this 
research, including the use of root bark powder instead of traditionally harvested and 
processed root and root bark. The researchers also infused the root bark powder in hot 
water instead of the decoction method that is used by all the consultants in this study.  
Another study by Heikes (1994) quantified the amounts of known carcinogenic 
compounds in commercial, un-brewed tea mixes, without actually heating the material. 
Both of these studies (Carlson & Thompson and Heikes) focused on finding a more 
efficient, cost-effective method of analysis than the official method adopted by the FDA 
in the 1960’s. Kapadia et al. (1978) did not prepare tea per se, but did extract in an 
aqueous solution using sassafras root bark. The researchers used petroleum ether, 
methylene chloride, and ethanol to extract the oil (which would include the safrole), and 
then injected 15 mg of the safrole-free ethanol extract in rats (Kapadia et al., 1978).  
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Traditional Knowledge & Implications for Chemical Analysis 
Traditional knowledge, especially in Native American communities, comes from 
a cumulative, inter-generational custom of passing along practices, beliefs, ideas, and 
wisdom. It is transmitted through cultural behaviors and generated by close contact with 
the natural environment. It encompasses every part of a society: politics, history, 
anthropology, and philosophy (Huntington 2005). The inherent complexity in natural and 
human social systems is recognized and categorized with the assumption that humans are 
a part of the web. Balance in natural systems requires reciprocity and respect. Knowledge 
is indigenous or traditional when “the meanings as well as the categories of sense making 
are generated internally within a cultural community”, as well as a physical environment 
(Gupta 2010; Viergever 1999).  
Within the system of traditional knowledge, traditional medicine is less a remedy 
or cure, and more of a way of balanced well-being. The World Health Organization 
defines it as, “the sum total of knowledge, skills and practices based on the theories, 
beliefs and experiences indigenous to different cultures that are used to maintain health, 
as well as to prevent, diagnose, improve or treat physical and mental illnesses” (WHO 
2008). When traditional medicine is taken out of context of its originating culture, it can 
be termed alternative or complementary medicine. Without the history or tradition to 
sustain them, medicines can be prepared or used differently from their original intention, 
sometimes leading to harmful results. This is not to say that traditional knowledge 
regarding plant preparation is invalid, only that if the product is of poor quality, taken 
inappropriately, prepared differently, or used at the same time as other medicines, the 
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product can be ineffective or malignant (WHO 2008). The traditional knowledge and 
particular species are often targeted, as in the case of sassafras tea, rather than if and how 
the knowledge was taken out of cultural context.  
People that use sassafras today look at the extended use of sassafras through 
history as proof of its safety. Steve Brill, a wild food forager in New York, states “People 
have enjoyed sassafras in moderation for thousands of years with no ill effects and 
consumed it in root beer before it was replaced by artificial chemicals. I think sassafras is 
safe” (Brill 1994). A home remedy book, or do-it-yourself herbal, says, “Everyone knows 
that sassafras has been used for centuries as a spring tonic. Try it, it’s delicious” 
(Williams 1998). Unfortunately, there are instances of injury from traditional methods 
prepared incorrectly. For example, a case study published in the Journal of Postgraduate 
Medicine describes an elderly woman who complained of diaphoresis. The doctor traced 
the excess sweating and hot flashes to her recent habitat of consuming ten cups of 
sassafras tea a day, as instructed by a family member (Haines 1991). The article does not 
indicate how strongly she prepared the tea or exactly how many ounces she consumed 
from ten cups. Another case study from 1987 reports a 47-year-old woman ingesting a 
teaspoon, or 5mL, of sassafras oil and immediately vomiting, followed by trembling 
(Grande & Dannewitz 1987).  
There have been many studies highlighting the importance of traditional methods 
of preparation, including several on safrole-containing species. This research closely 
followed the study of Reynertson et al. on a bark tea made from Cinnamomum 
carolinense, a study that specifically examined the differences in extracting the bark 
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using alcohol versus water (2005). Research in Egypt studied safrole-containing spices 
collected in local markets for the degradation of safrole during common cooking methods 
(Farag & Abo-Zeid 1997). A wild ginger species (Asarum spp.) used in traditional 
Chinese medicine was analyzed before and after a one-hour decoction (Chen et al., 2009). 
The kava-kava controversy is well known in the health food circle for multiple cases of 
severe liver damage when the roots are extracted with ethanol or acetone rather than the 
traditional method of maceration in water and coconut milk (Singh & Devkota 2003; 
Whitton 2003).  
It is important to remember as well that plant medicine is most likely derived 
from secondary compounds produced for protection against herbivores, pathogens, fungi, 
and other modes of attack. Plants have evolved a myriad of defense mechanism, from 
neurotoxin effects that can cause confusion or sedation to physiological effecting, 
including growth suppression or organ damage. These secondary compounds, often very 
toxic to predators, can be harnessed by humans for beneficial effects (Briskin 2000).  
The purpose of this research was not to discredit or devalue the traditional 
knowledge that informed this study. Native American cultures have been using sassafras 
for centuries, along with other plant species with deadly and toxic compounds. As of the 
conclusion of this study, there have been no confirmed, direct linkages between drinking 
sassafras tea and harm reported in any CDC Morbidity and Mortality Report or the FDA 
MedWatch program (CDC 2012; MedWatch 2012). These programs are the monitoring 
methods used by the FDA to follow any adverse, unexpected, or unusual results of 
consuming FDA-regulated products (Love 1999).  
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CHAPTER THREE 
TRADITIONAL KNOWLEDGE OF PREPARING SASSAFRAS TEA 
 
Introduction 
The methods and materials used in this study of harvesting, processing, and 
preparing sassafras root are based on discussions with enrolled members of the EBCI and 
non-Cherokee persons. These people have made sassafras tea for much of their lives and 
many were taught as children by their parents or grandparents. They were consulted on 
their methods of making tea in order to create a specific formula for tea-making to be 
used as the ‘standard’ in the laboratory, a process that is replicable and uses specific 
quantities. The ‘standard’ method represents a typical way to prepare tea and was a 
compromise between slight differences among the processes. The harvesting, processing, 
and preparing techniques varied with the consultants, including the age and habitat type 
of the sassafras tree, how the root was processed for tea and storage, the proportion of 
root to water in making the tea, and the length of time the root was boiled and steeped.  
 
Traditional Harvesting, Processing, and Preparation 
The processes included on harvesting, processing, and preparing sassafras root 
represent one way of demonstrating how decisions were made for this research and do 
not imply the totality of processes or people who use sassafras. Many consultants 
harvested saplings because they are abundant, easier to dig up, and are considered weedy 
by some homeowners. Some consultants dug from both young and mature trees. A few 
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indicated they dug roots in certain seasons, including only in late fall, winter, or early 
spring, as these were when the plant energy was concentrated in the root. The processing 
step was the most variable among root harvesters: some consultants dried the root spread 
on newspaper, while others hung them in bags. The consultants either chopped the root 
into chunks of various sizes and weights, whittled the root lengthwise into strips, or kept 
the smaller, thinner roots whole. In making the tea, the root was boiled from 10 minutes 
up to an hour, removed from the heat source, then let steep for a few hours, overnight, or 
up to 24 hours.  
There were several points of general agreement among the consultants. They all 
emphasized the sustainable harvest of the root as to not to harm the larger trees, or only 
harvesting saplings if they are considered weedy or in a site about to be bulldozed. Every 
consultant indicated that they left the root bark on the roots, washed the root very 
thoroughly after harvesting, and hung the root in breathable containers, most commonly a 
mesh onion bag. Breathable containers are essential to keep the dried root from molding. 
The consultants agreed that dried root would last many years, though typically it was 
used in one-year period due to steady use.  
All the consultants agreed on the proper color of the tea, though many found it 
difficult to describe: light brown, almost see-through, yellowish-brown, medium honey-
colored, or the color of amber beer (See Figure 3.1). Any lighter and it would be too 
weak tasting, and any darker it would overpower the senses. Many described the amount 
of root to be used in a pot or single cup of tea in terms of handfuls, as in a double handful 
of root per kettle of water or one chunk of root for a mug of water. The art of making 
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sassafras tea is in the experience and practice of knowing how strong the root smells as to 
how strong the tea will be, and checking on the steeped tea for the color and taste. The 
amount of root and water and how long it is boils and steeps is secondary to the color, 
smell, and taste. The more root you use, the faster it will steep, while the less root used, 
the longer you steep it. 
Tea is made with either fresh root or dried root, and there seemed to be no 
preference for either type. Dried root needs to be rehydrated in order to release the flavor, 
which can be done by boiling the root once, letting it steep overnight, and boiling again 
the next morning and let steep again, or by letting boil and steep for a longer period of 
time. For the amount of tea to drink, the consultants were all in agreement. If a person 
was sick, they should have about three cups of tea, otherwise one to two cups a day is 
enough. Tea is typically consumed in the fall, winter, and spring, especially in the spring 
months when people are liable to get sick or prepare for the changing season. Fresh tea is 
best, but if a big pot is made it can be kept in the refrigerator for up to a week.  
 
Field Methods: Harvesting 
All roots were dug within two weeks during July 2011 on property managed by 
either the Highlands Biological Station or the Highlands-Cashiers Land Trust. All the 
land was within Highlands, North Carolina, a small town in the southern plateaus of the 
Blue Ridge Mountains. Many of the harvesting sites were around 3,800 feet in elevation, 
with one site at 4,100 feet. Sassafras trees grow prolifically at this elevation and habitat, 
which is classified as temperate rainforest (Chamber of Commerce 2011).  
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Figure 3.1: Traditionally prepared sassafras tea.  
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  A total of nine trees were harvested for an average of 40 grams of root material 
per tree. The terrain shape index, landform index, and diameter at breast height (dbh) 
were measured for each of the trees, and the habitat type was described. The roots were 
removed with hand shears, and the soil samples were collected from around the 
excavated roots, to a depth of six inches. Soil samples were analyzed by the Clemson 
University Agricultural Services Lab for general soil properties and nutrients. With the 
exception of one site (Site 7), all the primary nutrients (nitrogen, potassium, and 
phosphorus) were in the low medium to low range recommended for adequate plant 
growth. The soils in all the sites were moderately to extremely acidic, with an average 
soil pH of 4.23 ± 0.6 (optimum soil pH for plants is 5.8 to 6.5). See Table 3.1 for 
complete descriptions of harvest trees and sites. 
Positive root identification was achieved by following a large surface root three to 
four feet from the tree bole. The surface root sometimes dipped into the soil, where it was 
followed by tunneling along the root. Identification was also attained by olfactory 
identification of the excavated root, which smells characteristically of ‘sweetshop’, candy 
store, or ‘spicy’ when fresh. The two young saplings that are included in the sampling 
were dug up completely and the entire root system up to the main root of the colony was 
collected. Only trees approved by the Highlands-Cashiers Land Trust or the Highlands 
Biological Station were harvested.  
The size and shape of the roots is most likely dependent on the age of the tree, site 
conditions like soil type and slope, and size of the colony, if part of one. Observations 
were made that the older trees had much thicker, darker roots, almost a deep reddish-
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brown color, with potent smelling roots that smelled characteristically like a sweet-shop 
and earthy. Soil surrounding older roots had a very strong sassafras smell. Young 
saplings, three or four years old, had roots that were much lighter in color with a sharper, 
sweeter smell then the older trees without the associated smell in the soil. Surface roots, 
or roots typically acting as suckers in a colony, were very pliable and thinner compared to 
non-surface roots.  
 
Field Methods: Processing 
The roots were washed thoroughly (carefully keeping the root bark) in tap water 
and weighed on a Mettler H51 balance scale with 0.01 g precision. The length and 
diameter were measured with a digital caliper. The roots were dried on paper for a 
minimum of 48 hours to prevent mold growth, and then placed in separate brown paper 
bags until prepared for samples. The bags kept in an open box in a well-ventilated room 
until they were boiled for tea.  
When the roots were dry, they were weighed and measured again. The roots had 
an average moisture loss of 61% when air-dried, or ranging between 51% to 67% 
moisture loss. One 4 g sample was dried in an oven for 6 hours, or until the dried weight 
did not fluctuate, where it lost a further 9% moisture, for a total of approximately 70% 
moisture difference between dried and fresh root.   
The air-dried dried roots were cut into segments that each weighed from 0.1 g to 1 
g approximately (See Figure 3.2). The segments were mixed together in equal parts, 10 g 
from each tree, so each tree root represented one-ninth of the total weight. When root  
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Site # Height 
(feet) 
DBH 
(inches) 
Habitat Slope Soil 
pH 
1 17 3.6 Acidic upland with Rhododendron 
and Vaccinium, part of a colony, 
sandy loam soil, understory 
North facing, slight 
slope 
3.4 
2 12 1.8 Acidic upland with Rhododendron 
and Vaccinium, part of a colony, 
sandy loam soil, understory 
Southwest facing, 
slight slope 
3.9 
3 15.5 2.2 Acidic upland with Rhododendron 
and Vaccinium, part of a colony, 
sandy loam soil, understory 
Southwest facing, 
slight slope 
4.5 
4 <6 <1 Acidic upland with Kalmia, 
Rhododendron, and Vaccinium, 
Rocky, sandy soil, understory in a 
windy, exposed mountainside 
Southwest facing, 
very steep 
4.1 
5 17 2.2 Oak-hickory forest, understory 
and part of a colony 
Southwest facing, 
slight slope 
4.3 
6 57.5 28.8 Acidic soil with dense covering of 
Rhododendron and Kalmia, 
roadside 
South facing, steep 
slope. 
4.1 
7 <6 <1 Sapling on disturbed site, roadside South facing, slight 
slope 
4.9 
8 49 12.5 Old-growth, acidic upland forest 
with Rhododendron. Is dominant 
in the canopy with no colony 
West facing, some 
slope 
3.6 
9 <6 <1 Sapling in open, disturbed site 
with full sun. Part of a colony of 
saplings 
South facing, no slope 5.3 
 
Table 3.1: Site and tree characteristics for Sassafras albidum trees harvested in 
Highlands, North Carolina.  
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segments were selected for preparing the tea, the bag was shaken thoroughly and root 
segments were chosen blindly and at random. Oven-dried root segments were not used in 
tea preparation as someone would not normally dried the root in the oven before making 
tea. 
Field Methods: Preparing 
The traditional method of preparing tea was standardized to consistently produce 
a cup of sassafras tea with approximately the same color and smell each time. This was a 
subjective observation, but acceptable for this study as tea is consumed with a wide range 
of color and smell intensities. Just as a variety of tree age classes and habitats are 
harvested, a variety of preferences exist within tea preparation. As the consultants drank 
tea within this spectrum of tea intensities, we intended to cover the range of tea consumed 
to reflect any differences in safrole content. Once a standard time of boiling, steeping, 
and re-boiling was established, the standard method did not change to accommodate 
changes in tea color.  
The roots were boiled twice: once to rehydrate the roots, which were then left to 
steep ‘overnight’, then boiled again to make the tea. The water and root are heated 
together to boiling (when the water started visibly bubbling), which marked the 
beginning of the boil time. The heat source is turned down to ‘medium’ to simmer for 15 
minutes (See Figure 3.3). The tea was removed from the heat source and left to steep 
‘overnight’ for 12 hours without refrigeration. The second boil was performed as the first, 
or the root and water brought to a roiling boil together, with the time beginning at first  
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Figure 3.2: Segments of dried sassafras root chopped into small pieces.  
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Figure 3.3: Sassafras root being actively boiled while preparing the traditional method 
samples.  
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signs of boiling. The tea was allowed to actively boil for 20 minutes and removed from 
the heat source. The root segments were used once for each replicate of each sample. 
 
Results and Discussion 
 The standardized method described in this section was based on conversations 
with people knowledgeable in the use of the species. This standardized method, 
particularly in the preparation steps, is as similar to the traditional method as could be 
replicated in a laboratory setting (using distilled water, hot plates, and laboratory 
glassware instead of kitchenware). Future studies might look closely at the traditional 
knowledge of sassafras, including the range of harvesting, processing, and preparation 
methods.  
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CHAPTER FOUR 
CHEMICAL ANALYSIS USING HPLC  
 
 
Introduction 
 The objective of this chemical analysis was to quantify the amount of safrole 
found in both the method outlined in the FDA regulation and the traditional method of 
preparing sassafras tea. A third sample set, the agitate samples, was added to measure the 
concentration of safrole present in the root without degrading the safrole with heat 
extraction. The samples were run through a high-performance liquid chromatography 
(HPLC) system using a reverse-phase C18 column method. The FDA used gas 
chromatography in the 1960’s to detect and quantify safrole, but the developments in 
sensitivity and reliability of HPLC lead us to use this method (CFR Sec. 189; Larry 
1970). Also, many recent papers have used HPLC to quantify safrole, including a paper 
by Reynertson et al., 2005 from which we adapted the methodology for the chemical 
analysis. This paper was used as a model because the study was recent, so it utilized 
modern analytical techniques, and because the research closely paralleled the 
ethnobotanical objectives of this project.  
 Plant material is inherently variable, particularly in the concentration of secondary 
compounds. The time of day or season of the year, soil and microclimate, herbivory and 
pathogen activity, and age and history of a particular tree can determine specific chemical 
quantities. The experiment was designed to encompass the spectrum of harvest and 
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preparation styles, as well as variation among young or mature trees and different habitats 
and elevations.  
 
Materials and Methods 
 
Laboratory materials 
- Safrole standard (98%) – Chem Service Inc. in West Chester, Pennsylvania.  
- ACS-grade MeOH and HPLC-grade ACN – Fisher Science in Georgia.  
- Water – deionized 
- YMC ODS-AQ S-8 4.6 x 250mm, 5μm, 120Å HPLC column 
 
Traditional Method 
Samples 1a, 2a, and 3a (see Figure 4.1 for chart of the samples) were prepared by 
boiling 2 grams of air-dried root segments in a 500 mL glass Erlenmeyer flask with 300 
mL distilled water, using two hot plate/stirrers (VWR Scientific Products 370 and Fisher 
Science). A small piece of aluminum foil was loosely placed over the top of the flask to 
reduce water evaporation. The samples were prepared as described in Chapter 3, or 
boiled for 15 minutes, let steep for 12 hours, and re-boiled for 20 minutes.  
Fifty micrograms (50 μg) of safrole standard was added to the samples 2a, 3a, 2b, 
and 3b, following the methods in Reynertson et al. 2005. These spiked samples would 
show whether safrole is degraded without complication of root material.  
The traditional method samples were run twice due to the inconsistency of the 
results in the first run. Each sample set of the traditional methods has six samples 
whereas the FDA method and agitate sample set contains three samples each.  
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FDA Method 
The FDA samples were prepared based on the generalized methods defined by 
regulations. Sassafras extract is the aqueous solution “obtained by extracting the bark 
with dilute alcohol, first concentrating the alcoholic solution by vacuum distillation, then 
diluting the concentration with water and discarding the oily fraction” (CFR, Sec. 172). 
 Samples 1b, 2b, and 3b were prepared using ACS grade methanol diluted to 80% 
methanol in 500 mL glass Erlenmeyer flasks. Each of the FDA samples were stirred 
using a stir plate and stir rod for 35 minutes, or the same boil time of the traditional 
method samples. Following the methodology outlined by the FDA, vacuum distillation 
was done using a Büchi Rotovap. The heating bath was set at 65°C, the evaporation point 
of methanol. The solution was diluted back to 300 mL using distilled water. The solution 
was poured into the funnel separator, allowed to settle for 10 minutes, and then run 
through the separator until 5 mL remained. The remaining liquid in the funnel separator 
represented any sassafras oil found in the root and was not included in the analyzed 
sample. The remaining aqueous solution (after removal of the oil fraction) had no 
detectable oil, characteristic sassafras scent, or color.  
 
Agitate Samples 
The agitate samples were prepared with 10 g of root and 300mL of cool distilled 
water. The samples were stirred with a stir plate and stir rod for 50 minutes, let sit for 20 
hours, and filtered. The agitate sample went through a longer period of agitation and 
steeping until the color of the resulting samples was close to color of the traditional tea 
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samples. The color was not standardized but based on the descriptions provided by the 
consultants. A larger quantity of root was added for the same reason. No heat was applied 
during any part of the process and the stirring was kept at a low, steady speed as to not 
cause excess heat. The resulting concentration was divided by five to compensate for the 
increased amount of root but no correction was taken for the increased time of agitation.  
 
HPLC Analysis 
All samples were filtered through 0.2 μm syringe filters prior to analysis. Analysis 
was performed on a Shimadzu Prominence UFLC (Ultra-Fast Liquid Chromatography) 
system using a reverse-phase C18 column (YMC ODS-AQ S-8 4.6 x 250mm, 5μm, 
120Å). Results were monitored at 235 and 254 nm using UV detection. The mobile phase 
consisted of two solutions, (solvent A) distilled water and (solvent B) acetonitrile (ACN). 
The HPLC conditions were as follows: linear gradient of 5% (B) at 5 minutes, 15% (B) at 
10 minutes, and 100% (B) at 45 minutes for 10 minutes, with a stop time of 55 minutes. 
The injection volume was 10 μL. Retention time for safrole standard was 37.77 ± 0.23 
minutes (See Figure 4.1).     
The Limit of Detection (LOD) and Limit of Quantification (LOQ) were calculated 
based on the blank determination method cited in Sanagi et al., 2009. LOD is the lowest 
concentration of a compound that can be detected, but without the need to specifically 
quantify the concentration. LOQ is the lowest quantifiable concentration identified by the 
analytical procedure. LOD and LOQ are important analytical validations that define the 
limits of the analytical laboratory machine (Sanagi et al., 2009). There are many accepted 
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methods for quantifying LOD and LOQ, including the blank determination method 
outlined in Sanagi et al. (2009). The blank determination method was chosen for this 
study as the method is applicable when a blank sample returns results with non-standard 
deviations. LOD and LOQ is calculated by running at least three blank samples with no 
standards or compounds added. The mean concentration and mean standard deviation of 
the blank are found. LOD is the concentration of the blank sample plus three standard 
deviations (xm + 3Sd) while the LOQ is the analyte concentration of the blank sample plus 
ten standard deviations (xm + 10Sd), where (xm) is the mean concentration and (Sd) is the 
standard deviation (Sanagi et al., 2009). 
LOD and LOQ measured 1.514 ppm and 2.049 ppm for 235nm, respectively. 
Triplicate samples of diluted safrole standard of 10, 50, 100, 200, and 1000 ppm were run 
to configure a standard curve. Standard curves were calculated for 235 nm absorption, 
yielding the following equation which with to calculate the amounts of safrole present in 
the samples. For 235nm absorption: the equation was [Area = 628.2326*Concentration], 
as seen in Figure 4.2. For the 235nm absorption, the p-values for the intercept variable (or 
‘b’ in the equation y = mx + b) were greater than the level of significance, meaning it is 
not included in calculating the sample concentrations. The R-squared value for 235nm 
absorption was 0.9579. P<0.05 was considered statistically significant. Based on the 
absorption spectrum of safrole, the 235 nm wavelength was determined to be a more 
stable absorption time and therefore was the only wavelength reported in these results.  
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Number Sample Extraction 
Method 
Purpose 
1a Root Traditional Quantify the presence  
or absence of safrole  
2a Safrole Standard  Traditional No root, to ensure traditional  
method eliminates safrole 
3a Safrole spiked Root Traditional Quantify amount of degradation 
1b Root FDA Quantify safrole to compare to #1a 
2b Safrole Standard FDA No root, to compare to #2a 
3b Safrole spiked Root FDA Quantify amount of degradation  
Agitate Root Cold water To extract unaltered safrole using 
water 
 
Table 4.1: Table of samples, extraction methods, and purpose of sample type in 
preparation of HPLC analysis. Traditional method samples are signified with the letter ‘a’ 
after the sample number while FDA method samples have the letter ‘b’ after the sample 
number. 
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Figure 4.1: Safrole standard (5,000 ppm), detected at 235 nm with an elution time of 
37.775 minutes. 
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Figure 4.2: Standard Curve for 235 nm absorption. The equation generated by the linear 
regression: Area = 610.03*Concentration. Triplicate runs of 10, 50, 100, 200, and 1000 
ppm of safrole standard are indicated by red open circles. Upper and lower 95% 
confidence intervals represented by dotted lines. 
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Sample PPM  
Mean 
(PPM) 
Std Dev 
1a-1 7.206 
  
1a-2 0 
  
1a-3 9.055 
  
1a-4 8.917 
  
1a-5 6.198 
  
1a-6* 35.36 6.275¹ 3.707 
2a-1 0 
  
2a-2 1.854 
  
2a-3 0 
  
2a-4 0 
  
2a-5 0 
  
2a-6 0 0.309 0.757 
3a-1 26.09 
  
3a-2 13.80 
  
3a-3 18.36 
  
3a-4 5.880 
  
3a-5 9.653 
  
3a-6 0 12.30 9.258 
1b-1 0 
  
1b-2 0 
  
1b-3 0 0
1
 0 
2b-1 0 
  
2b-2 0 
  
2b-3 0 0 0 
3b-1 0 
  
3b-2 1.93 
  
3b-3 0 0.644 1.12 
Agitate-1 21.25 
  
Agitate-2 24.12   
Agitate-3* n/a* 22.69
1
 2.033 
 
Table 4.2: Results of HPLC analysis in parts per million (PPM) of safrole at 235nm. The 
mean and standard deviation of each of the sample sets is listed.  
*Samples 1a-6 and Agitate-3, were removed from the sample sets as the results were 
outliers or due to a contaminated column. The concentration was determined by the 
calibration curve.  
1
Samples 1a are significantly greater than the samples 1b and significantly less than 
Agitate 1 & 2 samples based on student t-tests at α=0.05 
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Sample 
Average 
Safrole in mg/ 
300 mL 
Std. 
Dev. 
Average 
Safrole in 
ppm or 
mg/L 
Std. 
Dev. 
1a 188.2 111.2 627.5 370.7 
2a 9.27 22.7 30.9 75.7 
3a 368.9 277.7 1229.7 925.8 
1b 0 0 0 0 
2b 0 0 0 0 
3b 19.3 33.5 64.48 11.67 
Agitate 680.6 61.0 2268.7 203.3 
 
Table 4.3: Milligrams and ppm of safrole per 300 mL of aqueous solution. 
Concentrations calculated from Table 4.2. 
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Sample Safrole in mg/ kg Std. Dev. 
1a 3.14 1.85 
2a 0.15 0.38 
3a 6.15 4.63 
1b 0 0 
2b 0 0 
3b 0.32 0.56 
Agitate 11.34 1.02 
 
Table 4.4: Milligram of safrole hypothetically consumed by a 60 kg person. 
Concentrations calculated from Table 4.3.  
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pH of Traditionally Prepared Tea 
 The pH of three separately prepared, traditional tea samples was quantified using 
a pH probe. The probe was rinsed with distilled water, inserted into the tea sample, and 
rinsed again with distilled water. The traditionally prepared tea samples were prepared 
following the methods listed above.  
 
Results 
 
Concentrations in ppm of the HPLC analysis of the traditional, FDA and agitate 
samples can be seen in Table 4.2. One sample prepared using the traditional method with 
root only (1a-6) was discarded as an outlier with a large Cook’s distance. Sample labeled 
Agitate-3 in Table 4.2 was discarded due to contamination of the column.  
 The methods outlined in the paper by Reynertson et al., 2005 were followed in 
preparing comparative samples, namely the spiked samples (2a, 3a, 2b, & 3b). The 
samples 2a and 2b were prepared with 50 μg safrole standard while the samples 3a and 
3b were prepared with root and 50 μg safrole standard, as outlined in Table 4.1. When 
calculating the concentration of safrole standard added to the samples, the amount 
suggested by Reynertson et al. (2005), it was discovered that the amount was too small to 
be detected by the HPLC system. In a 300 mL solution, 50 μg contributes a concentration 
of 0.67 mg/L, or 0.67 ppm. The LOD and LOQ for this system were 1.514 ppm and 
2.049 ppm. Unfortunately, these samples could not be used in discussion of the results of 
the chemical analysis.   
The agitate samples were intended to provide a baseline amount of safrole found 
in the root and extracted with water. We compared the agitate samples to the traditionally 
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prepared teas to observe how the quantity of safrole differs between samples being 
actively heated and boiled and those samples simply being agitated. Although the agitate 
samples were agitated longer than the traditional methods, the samples were prepared 
based on color just as a person making sassafras tea will judge the readiness of the tea on 
its color. The elevated amount of root in the agitate sample was compensated by dividing 
the concentration by five, as five times as much root was used. It was interesting to note 
that while the agitate samples did not have the characteristic sassafras smell, but they did 
have a woody, earthy smell that was not unpleasant.  
Based on a student t-test, the concentrations of the traditional method samples 
were significantly greater than the FDA method samples (P <0.05) and significantly less 
than the agitate samples (P<0.05) based on α=0.05. 
  
Observations and Discussion 
We found three important points of discussion from the chemical analysis. First, 
the FDA method was extremely efficient at removing the safrole oil by agitation using 
organic solvents. There was one sample with a small amount (1.878 ppm) of safrole 
present, but this is probably due to imperfect laboratory procedures and not a reflection of 
the methodology. We observed that the resulting liquid from the FDA method was 
odorless and colorless. There was no characteristic sassafras smell associated with the 
liquid and therefore, it may be unappealing for a marketable product.  
The second observation related to the results of concentrations of the agitate and 
traditional method samples, as listed in Table 4.3. The average safrole concentration of 
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the agitate samples was 2268.7 ppm ± 203.3, or 681 ± 61.0 mg of safrole per 300 mL of 
aqueous solution. The traditional method of preparing sassafras tea (Sample 1a) resulted 
in an average concentration of 627.5 ± 370.7 ppm or 188 ± 111.2 mg of safrole per 300 
mL of aqueous solution. Based on these results, the traditional method samples have 3.6 
times fewer grams of safrole per cup (300 mL) of tea as compared to agitate.  
Since essential oil composes 6-10% of the weight of the root cortex of sassafras, 
and safrole composes 80-90% of the essential oil, by taking the highest estimates the root 
contains around 9% safrole (Carlson & Thompson 1997; Kamdem & Gage 1995). A cup 
of tea, or around 300 mL, is typically prepared with 2 grams of root. We would then 
expect the cup of tea to contain 180 mg of safrole oil. The traditional method samples 
contained 188 ± 111.2 mg of safrole per cup, or close to the expected concentration. On 
the other hand, roots extracted with water by agitation yielded 681 ± 61 mg of safrole per 
300 mL of tea. It is difficult to compare this experiment to previous research as the 
methods to agitate the sample are going to differ with each study, but it was interesting to 
note the difference between the amount of safrole we expected to find and the amount of 
safrole extracted by aqueous agitation. The study by Carlson & Thompson (1997) 
showed an 88.9% reduction of safrole from the unbrewed teas compared to the brewed 
teas. The study found ranges of 0.18 – 16.0 mg/g product in unbrewed teas that were 
reduced to 0.09 – 4.12 mg/g product in the brewed teas.  
Chemically, it seems unlikely that using a polar solvent (water) to extract a non-
polar solute (safrole oil) should extract more oil than a non-polar solvent (methanol or 
another organic solvent). Safrole is miscible in alcohols, not water (Kamden & Gage 
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1995; Sethi et al., 1976). Though, it is difficult to compare the studies as many journal 
articles do not detail extraction processes. However, it is possible to say that boiling the 
root as in the traditional method aided in reducing the concentration of safrole in the 
resulting aqueous solution, as compared to the agitate samples.  
The third and last observation relates to the literature on safrole content and 
regulations. Returning to the previous calculations, if we expect one cup of tea with 2 
grams of root and root bark to have about 180 mg of safrole, a person weighing 60 
kilograms would consume 3.0 mg of safrole per cup. This calculation is supported by a 
similar estimate by Segelman et al. (1976) who calculated 3.0 mg/kg safrole is found in 
one tea bag containing 2.5 g of sassafras bark. We found that sassafras tea has 188 ± 
111.2 mg of safrole per cup (300 mL) of tea, as listed in Table 4.3. Therefore, a 60 kg 
person would consume 3.13 ± 1.85 mg/kg bw of safrole per 300 mL of tea (Table 4.4). A 
person consuming agitated, non-boiled tea would be consuming 11.34 ± 1.02 mg/kg bw 
of safrole per 300 mL. The United States FDA does not allow the presence or addition of 
safrole to any foods or beverages and the European Commission of the European Union 
allows the presence of safrole in foods containing nutmeg and mace only up to 15 ppm. 
Traditional tea, according to this study, has around 628 ± 370.7 ppm of safrole per 300 
mL (Table 4.3). 
 Using the Body Surface Area (BSA) dose translation formula discussed earlier, a 
60 kg person would consume 3.14 mg of safrole, which is equivalent to a dog consuming 
5.8 mg/kg bw. A study by Hagan et al. (1965) conducted a six-year study that 
administered safrole to dogs in doses of 5, 20, 40, and 80 mg/kg bw. After six years, with 
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the dogs receiving a tablet six days a week, the dogs experienced microscopic, minimal 
focal necrosis, bile-duct proliferation, fatty metamorphosis, and hepatic cell atrophy 
(Hagan 1965). Another study with dogs that spanned seven years found liver injury early 
in the experiment, but hypothesized that the lack of damage found later in the study was 
due to adaptation to the continuous intake of safrole (Weinberg & Sternberg 1966).  
The dose equivalent for rats would be 19.4 mg/kg bw. As stated before, many 
toxicity studies administer doses in the range of 100 to 1000 mg/kg bw, though Daimon 
et al. (1998) tested single doses of 1, 10, 100, 250, and 500 mg/kg bw. Two DNA-safrole 
adducts per 10
7
 nucleotides were found after a dose of 10 mg/kg bw, while a 1 mg/kg bw 
dose did not produce adducts and a dose of 100 mg/kg bw produced two major and two 
minor adducts per 10
7
 nucleotides. Friedman et al. (1971) found that a 10 mg/kg dose of 
safrole had no effect on microsomal enzyme activity, which aid in the detoxification 
process. Chang et al. (2002) found the metabolic saturation of safrole occurred between 
150 and 300 mg/kg for rats, or much greater than the amount of safrole found in a cup of 
tea. Saturation of safrole means the body cannot eliminate the compound quickly and the 
safrole accumulates in tissue muscle, especially in the liver and kidneys, to increase the 
risk of DNA adducts and carcinogenesis (Benedetti et al.,1977). 
Based on these few studies, there was no indication that rats or dogs fed safrole at 
the amounts listed above developed liver tumors or cancer. There are not enough studies 
that have tested these particular doses on laboratory animals to conclude with certainty 
that the amount of safrole found in sassafras tea will lead to carcinogenesis. These few 
studies are promising, but more research needs to be conducted.  
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Plant secondary compounds, used by the plants for defense against predators and 
pathogens, are utilized by humans for the same purpose, to rid the human body of disease 
by way of pharmaceuticals (Bourgaud et al., 2001). Secondary compounds must be used 
properly, as the same compounds that humans harness to starve off disease can harm the 
body. Safrole is a proven hepatocarcinogen to laboratory animals, causing macro- and  
microscopic liver lesions, liver tumors, inability to gain weight, and reduced feeding (Jin 
et al. 2011; Long et al., 1963; Miller et al. 1983; Taylor et al., 1964). These symptoms 
exhibited by laboratory animals make sense when we consider the traditional medicinal 
qualities of sassafras tea, including ‘overfatness’ and to thin the blood during the change 
of seasons, especially during the spring (Moerman 2011). Considering the laboratory 
tests use high doses of safrole compared to the amount of safrole found in traditional tea, 
we can hypothesize that the extreme symptoms observed in laboratory animals occur to 
some degree in those drinking sassafras tea, but possibly to the human advantage. While 
laboratory rats had difficulty gaining weight or had a reduced appetite while consuming 
safrole, humans perhaps used small amount of safrole in sassafras tea to help shed winter 
pounds. A seven year study of administering safrole to dogs found evidence of liver 
injury early in the research but not late in the study. The researchers suggested the dogs 
adapted to the continuous intake of safrole and regenerated the damaged liver tissue 
(Weinberg & Sternberg 1966). 
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Reduction of Safrole during Boiling 
A handful of studies have attempted to explain the process that occurs when 
safrole-containing substances are subjected to heat. One study examined the spices star 
anise, cumin, black pepper, and common cooking ginger, which contain safrole in the 
essential oil, and found that washing, drying, and cooking the spices all reduced safrole to 
safe levels. Boiling the spices reduced the safrole content from 955 mg safrole per kg 
material in untreated seeds to 375 mg/kg in whole seeds boiled for one minute all the way 
to 9 mg/kg in powdered seeds boiled for five minutes (Farag & Abo-Zeid 1997). The 
study on a Chinese wild ginger reduced the 1.57 to 2.76 mg safrole per g material to 0.2 
mg/g or undetected in most samples after a one-hour decoction of the root (Chen et al., 
2009). Carlson & Thompson (1997) hypothesized that the lower safrole content in their 
sassafras ‘tea’ (the tea was infused not decocted) could have been due to either the 
decreased solubility of sassafras oil in water or volatilization of the compounds.  
Three chemical reactions could be occurring to reduce the safrole content in a cup 
of boiled tea. First, the essential oil, including the safrole oil, could be still in the root. 
Carlson & Thompson (1997) hypothesized that safrole content was reduced due to the 
insolubility of the essential oil in the root, which agrees with their finding of high 
recovery of safrole from alcohol- based sassafras oil tinctures. The second situation could 
involve volatilization of safrole as it is being heated. The compound has a low vapor 
pressure (0.0706 mm Hg at 25°C or 1 mmHg at 63.8°C), making safrole primarily a 
vapor at room temperature and pressure (Sigma-Aldrich MDMS S9652). If the compound 
was boiled at high temperatures for an extended period of time safrole would have some 
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volatility. Carlson & Thompson (1997) cited volatilization as well as reduced solubility 
of safrole in water for the reason safrole content was reduced an average of 88.9% from 
unbrewed to brewed tea. Many laboratory studies mention the volatilization of safrole 
from safrole-spiked rodent diet, which was left in open in room temperature. One study 
includes Homburger et al. (1965) that measured the evaporation rate of safrole to be 
11.3% per three day period (Crampton et al., 1997; Huang et al., 1999; Long et al., 1963). 
The last possibility is that safrole is being altered or degraded during the boiling 
process, as described in the Reynertson et al. (2005) paper. Reynertson et al. 
hypothesized that even though safrole is insoluble in water, insolubility is not the issue as 
samples spiked with safrole still resulted in no detected safrole. Since there were a 
number of degraded by-products after samples were boiled, it is probable that the safrole 
was not volatilized. Rather, the safrole was probably degraded during the boiling process 
by hydroxylation of the dioxolane ring. The hydroxylation could be due to the slightly 
acidic nature of the tea, which they measured at pH 4.4 (Reynertson et al., 2005). For this 
research, the average pH for the traditional method tea sample was measured at pH 5.1 ± 
0.1, which is considered acidic. 
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CHAPTER FIVE 
WORKING WITH NATIVE COMMUNITIES: EDUCATION AND OUTREACH 
 
Introduction 
During the research, we have collaborated with the Cherokee community, who 
continue to drink sassafras tea according to their traditional method. In addition, there are 
many non-Native people that grew up harvesting, processing, preparing sassafras, and 
drinking sassafras tea. The Cherokee best represents a cohesive community of people that 
maintain the knowledge and tradition of preparing sassafras tea. Since the Center for 
Cherokee Plants has worked to maintain and continue traditional knowledge of native, 
culturally signification plants, this work might not have been possible.  
 
Working with Native Communities 
This research, although not strictly participatory, is based on a model of working 
with Native communities through participatory research used by many researchers. In this 
model, research, education, and action are combined and research is based on the 
circumstances of the community. The researchers work to connect communities with 
resources, data, and scientific knowledge of benefit to them. There is an underlying 
assumption that communities will benefit from the research as resources are based on an 
“ecological give-and-take approach”, where knowledge, time, or mentoring by a 
community is returned to them through conscience acts of reciprocity (Davis & Reid 
1999; Cotton 1996).  
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Linda Tuhiwai Smith said, “The term ‘research’ is inextricably linked to 
European imperialism and colonialism. The word itself, ‘research’ is probably one of the 
dirtiest words in the indigenous world’s vocabulary” (1999). Unfortunately, many Native 
communities around the world have been exploited by researchers. Some research has 
even been harmful, especially research related to data collection and reporting on 
negative issues like alcoholism or drug addiction. Such research can lead to communities 
being ostracized or stigmatized, with participants feeling betrayed. In the worst cases, 
participatory research has left participants feeling invaded, patronized, or inferior, which 
is why many Native communities today have created strict rules to how and with whom 
research can be conducted on their land (Davis & Reid 1999).  
Anthropological and botanical studies in particular are in danger of being of little 
use to Native communities, and unfortunately some research on traditional medicines has 
been unconcerned with collaboration, effects of publication, or reciprocity. Given the 
history of medical, anthropological and archeological research, contemporary research 
projects with Native communities absolutely should be a collaborative effort between the 
community and the researchers. Christopher (2005) outlines several recommendations for 
non-Indian researchers, including involving the community from the formation of the 
question to the conclusion, as well as ensuring that the community has access to the 
research and results. The research should be based on values, concerns, and interests of 
the community and contain culturally-appropriate methodologies (Weaver 1997). The 
project should also have clear and immediate benefits for the community. Knowledge for 
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the sake of knowledge, according to activist and historian Vine Deloria Jr., should not be 
tolerated by Native Americans (1969). 
 
Collaborating with the Cherokee 
Although this project was concerned with the perceived toxicity of products made 
from Sassafras albidum, this research did not draw the official support of the tribe due to 
the historical use of sassafras for spiritual and medicinal purposes. However, we were 
able to work with the Eastern Band of Cherokee Indians Cooperative Extension to 
provide a means for education and outreach about the species. The Cooperative 
Extension acted as a ‘cultural consultant’ to advise us on the appropriate channels to 
distribute the research results (Weaver 1997). We planted sassafras trees and created a 
GIS map and pamphlets for the Center for Cherokee Plants (CCP), a project under the 
Extension office. The Center for Cherokee Plants, located between Cherokee and Bryson 
City, North Carolina and near the Kituwah mound, is a nursery that cultivates and 
experiments with Cherokee heirloom varieties of edible crops. They collect, save, and 
distribute seed within the tribe to encourage gardening with old varieties and healthy 
eating. The Center emphasizes youth and elder participation by establishing community 
and school gardens around the Qualla Boundary and projects including the Backyard 
Ramp Patch, Native Plant Study, Cherokee Community Greens Patch, and the Cherokee 
Farmers Market. They are the hub of agriculture and gardening in Cherokee as they work 
with community civic clubs and are connected with youth and elders alike. The Center is 
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a medium to encourage interactions between elders, adults, and youth and the exchange 
of traditional and indigenous knowledge (CCP 2011).  
By working with the CCP, we were able to hold discussions about sassafras tea 
and most importantly, give back to the community. Education and outreach comprise a 
significant part of this project for several reasons, including to disseminate scientific 
knowledge about the properties and safety of sassafras products and to highlight the 
cultural and historical importance of sassafras products. We promoted the use of sassafras 
in several ways: first, by planting a stand of twenty trees of sassafras on the property of 
the CCP, as seen in Figure 5.1. The CCP can decide in what ways they will use trees, 
either by harvesting material for demonstration purposes, allowing tribal members to 
harvest material for their own use, or as a physical reminder of how sassafras is a 
culturally significant species for the Cherokee. The trees also provide a basis for future 
research, ranging from topics on forestry to food chemistry. We also are in the process of 
creating pamphlets to be displayed with other educational material at the Cooperative 
Extension office in the city of Cherokee as well as at the Center for Cherokee Plants. 
Appendix A, focused on simple means of propagating sassafras, will be modified for 
these pamphlets. A copy of the thesis will be given to the Museum of the Cherokee 
Indian, which is also required for research under the auspices of the Tribal Research 
Committee, though we did not submit this research for their approval per their request 
(EBCI C.O., Sec. 70-3).  
We hosted a high school intern during Summer 2011 to complete a Geographic 
Information System (GIS) project to map the nursery grounds of the Center for Cherokee 
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Plants. The GIS map was made into a 3’ x 4’ laminated wall display and also into printale 
sheets for record-keeping. The Center asked not for the maps to be either replicated in 
print form, other than their own copies, or available on the internet, which we have 
agreed not to do. This is an example of how researchers need to be flexible to the wishes 
of the Native community which with they work. 
The continued use of sassafras trees for traditional foods and beverages could 
bring attention to land that is under development on the Qualla Boundary. Many current 
stands of sassafras in use by tribal members are open fields or sites slated for bulldozing. 
In the future, a non-timber forest product or products could be developed to sell if tribal 
members so desired. There could be potential for members of the tribe to petition the 
Food and Drug Administration based on this research, but more research and chemical 
analysis would most likely be needed before individuals could market and sell sassafras 
products. Appendix B contains more information on how to submit a petition to the FDA.  
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Figure 5.1: Stand of twenty sassafras trees planted at the Center for Cherokee Plants in 
Bryson City, North Carolina. The three-year-old trees were planted in Spring 2011. 
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CHAPTER SIX 
SUMMARY 
  
Sassafras tea is consumed today by many communities in the Southeastern United 
States, particularly in the Appalachian Mountains. Products made from the roots of 
Sassafras albidum have been banned from the market by the FDA due to the presence of 
the confirmed carcinogenic compound, safrole, based on tests using pure safrole standard. 
Toxicological studies typically test compounds by administering large doses of the 
compound to laboratory animals in order to understand the mechanisms of 
carcinogenesis. These studies are needed to understand the mechanisms but should be 
carefully analyzed when attempting to discuss the effects of ingesting safrole at daily 
levels. Before this project, no research had quantified the concentration of safrole in 
traditionally prepared sassafras tea. Additionally, no studied have used traditionally 
prepared teas in laboratory rodent cancer potency tests. Even though the number of 
people that consume traditional sassafras products is unknown, we can assume that many 
people grew up drinking the tea continue to consume it, as well as people that recently 
learned through herbal medicine guides. Due to the regular use of sassafras tea, it is 
important to understand any potential dangers associated with consuming products 
derived from the tree.  
 This study was informed by traditional knowledge of harvesting, processing, and 
preparing sassafras tea, as understood from conversations with members of the Eastern 
Band of Cherokee Indians (EBCI) as well as non-Cherokee well-versed in making 
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sassafras tea. The first objective of this study was to conduct chemical analysis using 
HPLC.  The intention was to compare the FDA method of extracting sassafras oil with a 
standardized process of preparing sassafras tea to quantify the amount of safrole present. 
An agitate sample was analyzed to compare the influence of heat on the quantity of 
safrole. The second objective was to return the results of this study to communities that 
utilize sassafras tea, namely the EBCI. We also emphasize the importance of reciprocity 
for the Cherokee community, who has dedicated their own resources to this project.  
  The results of the chemical analysis demonstrated that the FDA method was very 
effective at eliminating safrole entirely, as only one sample showed a miniscule amount 
of safrole. Additionally, analysis revealed that traditionally-prepared sassafras tea 
contains 188 ± 111.2 mg of safrole per 300 mL, or 0.63 ± 0.37 mg safrole per mL of 
solution. This is a safrole concentration of 628 ppm in traditionally prepared sassafras 
tea. Previous research examining the safrole content in root and root bark predicted a 
similar quantity of safrole, or 180 mg per 300 mL. On the other hand, the agitate samples 
from this research contained a higher concentration of safrole, or 680 ± 0.061 mg per 300 
mL, or 2.3 ± 0.2 mg/mL of solution. This is a concentration of 2269 ± 203.3 ppm, or 
more than predicted from previous estimates of safrole concentration in essential oil. As 
the agitate samples in this research used water as the extraction solvent (versus organic 
solvents used previously), it is difficult to conclude if safrole is reduced in the boiling 
process. If we assume the agitate samples in this study are the reference point of safrole 
content, then boiling does reduce the amount of safrole found in traditionally prepared 
tea.  
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 These three methods of extracting sassafras root resulted in important 
observations. First, the traditionally made sassafras tea had a pleasant smell and color - 
properties that many cultures associate with the tea. Second, the agitate samples did not 
elicit the characteristic sassafras smell and it took more root and time to achieve the 
desired color. Lastly, the FDA method resulted in a clear, odorless product with 
undetectable sassafras odor. In hindsight, the concentration of safrole found in sassafras 
tea may be serving some purpose, including simply contributing taste and scent 
properties to the tea or functioning medicinally.  
 In conclusion, this research contributes to a growing body of knowledge, both for 
those in the academic world as well as practitioners and caretakers of traditional 
knowledge. This research will serve at least two purposes: first, the results of this 
research will help people make informed decisions about their personal consumption of 
sassafras products. Second and more broadly, this will highlight the importance of 
traditional preparation methods when analyzing foods and beverages, especially those 
historically used by Native communities.  
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Appendix A 
Propagating Sassafras albidum 
Sassafras is notoriously challenging to propagate or even find in nurseries. Not 
only is it problematic to transplant (due to its deep taproot) but ripe seeds are difficult to 
find in the wild (Dirr 1998). The species is dioecious so only female plants produce seed, 
which are often eaten quickly by birds and wildlife. Greenish-yellow flowers produce 
single-seed drupes on red pedicles that turn a dark blue-purple when mature (Bonner 
2012). The species can be propagated from fresh, ripe seeds, dried seeds, cuttings, or root 
scions (Rasch 1998). 
 
Transplanting 
Sassafras can be grown in a container from seed and the tree transplanted any 
time of the year. A tree taken from the wild or from field plantings should be true 
seedlings (not root sprouts) that are transplanted in the late winter or early spring. The 
trees started by seed and grown in large pots until planting seem to transplant better than 
those transplanted directly from a field (Sternberg 2004). The colonal root system of 
sassafras, along with its deep taproot, makes it difficult to transplant saplings or trees 
easily. Root pruning in the late fall or early winter can encourage a tree to develop a 
healthy root ball before it is transplanted in the spring.  
When transplanting saplings, the tree should be balled and burlapped in moist, 
loamy, acidic, well-drained soil (Dirr 1998). About a third of the plant should be pruned 
to encourage root growth (See Figure A.1). If the main bole or branches break, as   
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Figure A.1: Transplanted and pruned sassafras sapling.
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brittle wood tends to do, then the stem is cut to the ground and a new stem will sprout. A 
sassafras thicket is obtained by cutting the stem back to encourage root suckers, but if a 
single stemmed tree is desired, the suckers should be removed (Sternberg 2004). 
 
Seeds 
Sassafras trees produce seed around 10 years of age (minimum of 4 years old) and 
reach maximum production from ages 25 to 50 with seed crops every year or every other 
year. Seed viability is around 35% and the seed can remain viable for six years on the 
forest floor. A study on Sassafras randaiense (Hayata) Rehder cited inhibitors in the seed 
coat and cotyledon that cull germination, requiring removal or scarification of the seed 
coat and followed by two to three months of cold stratification (Chen & Wang 1985). 
Sassafras seeds do not store well as they are an oily seed (versus a more starchy seed), 
with 47% lipid content (Bonner 2012). To break a natural dormancy of the embryo, the 
seeds need a cold-wet stratification with a period of 120 days at 41°F (5°C) in moist 
sandy or mineral soil (Bonner 2012; Griggs 1990; Haywood 1994). Germination can then 
be tested in sand or a germination soil mix at 70° to 85° F. (21-29° C) for up to 120 days.
 One method of germinating seed by the Woodlanders Nursery in Aiken, SC is to 
sow seed in a ‘community pot’, or a three-gallon container with well-draining potting 
soil. The seeds should be rehydrated in water for 24 hours, surface sterilized, and 
scattered in a sterilized three gallon pot of soil with a half inch of soil covering the seed. 
The community pot should be watered, covered with hardware cloth, and placed outside 
for the entire winter until the seeds germinate in the spring. The pot is dumped out and 
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seedlings separated to be potted individually (Bob McCartney, personal communication 
November 21, 2011).  
 
Root Cuttings 
A study by Sicuranza (2007) showed poor results for sassafras propagation from 
stem sprouts, but worthwhile results from root cutting propagation. It has been found that 
root cuttings yield plants with longer life spans, less root suckering, and better 
architecture than grafted plants (Orndorff 1977). Root cuttings are collected from October 
to December, when roots contain the highest percentage of carbohydrates, and placed in a 
2:1:1 peat, loam, sand mixture can be planted out successfully (Del Tredici 1995, Dirr 
1998). Some suggest taking root cuttings in February when the ground thaws and storing 
the roots in dry sand for three weeks before planted in sandy soil. If roots are harvested in 
the summer, Sicuranza (2007) showed July as the most successful month.  
Evans & Blazich suggest harvesting root pieces that are 5 to 10 cm in length in 
early winter. Del Tredici (1995) recommends root pieces that are 10 to 15 cm long for 
roots being planted outdoors in late fall or early winter. A straight cut is made on the end 
closest to the parent plant while a slanted cut is made on the opposite end (Evans & 
Blazich 2011). The roots need to be washed and fibrous roots removed. The root pieces 
are placed vertically in a moist medium, preferably pure sand or 1:1 peat to perlite mix 
with 10-20% sand. Griggs (1990) recommends placing stem sprouts vertically or larger 
roots horizontally. The straight cut, or where the root was closest to the parent plant, 
should be covered by 2 to 3 inches of soil (Evans & Blazich 2011). The medium and 
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roots are stored in a cool, dark location for three weeks until put in a warm greenhouse. 
There is a danger of water stress as the sudden warmth will cause shoots to develop 
before roots (Sicuranza 2007).  
 
Pests & Disease 
Foliage disease is the most prominent problem among S. albidum, along with a 
strong susceptibility to fire damage. Overall, sassafras is usually free from pests and 
disease, probably due to the strong presence of secondary defense compounds, but it does 
suffer from the occasional cankers, leaf spots, mildew, wilt, root rot, Japanese beetle, and 
sassafras weevil (Dirr 1998).  
 
Propagation Trials 
Sassafras seeds were collected in August in Clemson, South Carolina and left to 
air dry on newspaper. For these trials, the fleshy seed coats were allowed to dry and then 
removed manually, but Bonner (2012) recommends removing the pulpy flesh before 
storage or propagation by rubbing the seed over hardware cloth. Two methods of 
processing and cold-wet stratifying the seeds were tested. The first method involved 
removing the dried seed coat entirely, which can be done by carefully cracking open with 
a small knife or fingernail and extracting the round, light brown seed. The seeds were 
surface sterilized in a 10% bleach solution for 30 seconds, rinsed, and placed in a 
sterilized plastic snap-lid container with damp perlite. The second method leached the 
seeds of any chemicals that would inhibit germination. The seeds were placed in 
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cheesecloth like fabric and placed in a back toilet bowl for fourteen days. The seeds were 
scraped with sandpaper, surface sterilized, and placed in damp perlite.  
All containers were placed in the vegetable drawer of a refrigerator (at 41° F or 5° C) for 
four months. In March 2012 the seeds were sown in potting soil and placed outside to 
germinate. The seeds will be monitored for success rate of germination of either the 
leaching method or removal of seed coat.  
A third method of stratifying and germinating the seeds was a method 
recommended by Woodlanders Nursery in Aiken, SC, termed ‘community pot’ (personal 
communication, Nov. 21, 2011). This method (see above description) was begun for the 
experiment but unfortunately had to be terminated. Future studies in sassafras 
propagation should strongly consider this method.  
The propagations trials are still ongoing. In Fall 2011, a dozen sassafras saplings 
considered weedy by the landowner in Cherokee, NC were cut around with a sharp 
shovel to encourage a root ball. Six of the trees were transplanted in March 2012 and six 
more will be transplanted in Fall 2012 to the Center for Cherokee Plants. The saplings 
will be monitored to measure success rate of spring and fall transplanting. 
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Appendix B 
Petitioning the Food and Drug Administration 
According to the FDA website, the government agency receives about 200 
petitions a year (webpage last updated in 2008). The evaluation of a petition can take a 
few weeks or up to a year. The majority of the petitions come from industry and 
consumer groups, though individuals are allowed to submit petitions. There is a specific 
format for citizen petitions that must be followed for submission, which can be found by 
searching for Title 21 of the Code of Federal Regulations, Sections 10.30. It contains six 
parts: action requested, statement of grounds, environmental impact, economic impact (if 
applicable), certification, and identifying information.  
The code that specifically targets the use of sassafras bark to make sassafras tea is 
[Code of Federal Regulations: Title 21, Volume 3, Sec. 189.180 Safrole].  
The full title: Title 21 – Food and Drugs, Chapter I -- Food and Drug Administration, 
Department of Health and Human Services, Subchapter B – Food for Human 
Consumption (Con’t), Part 189 – Substances Prohibited from Use in Human Food, 
Subpart C – Substances Generally Prohibited from Direct Addition or Use as Human 
Food. Sec. 189. 180 Safrole.  
The code states in part (b), “Food containing any added safrole, oil of sassafras, 
isosafrole, or dihydrosafrole, as such, or food containing any safrole, oil of sassafras, 
isosafrole, or dihydrosafrole, e.g., sassafras bark, which is intended solely or primarily as 
a vehicle for imparting such substances to another food, e.g., sassafras tea, is deemed to 
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be adulterated in violation of the act based upon an order published in the Federal 
Register of December 3, 1960 (25 FR 12412)” (CFR, Sec. 189). 
Specifically, the petition should outline the confirmed carcinogenic properties of 
pure safrole standard and related metabolites in comparison to pivotal papers like 
Benedetti et al. (1977) that found a lack of 1’-hydroxysafrole (a carcinogenic derivative 
of safrole) in human subjects after ingestion of safrole. Next, the recent research on the 
non-toxicity of traditionally prepared foods, beverages, and medicines should be 
mentioned (Chen et al., 2009; Farag & Abo-Zeid 1997; Reynertson et al., 2005; Singh & 
Devkota 2003; Whitton 2003). The results of this research should be cited as well as any 
other future research on the toxicity or carcinogenicity of traditionally prepared sassafras 
products.  
Summaries of all the studies can be found in the following reviews:  
 Cropwatch.org/: Safrole 
 
 SCF. 2002. Scientific Committee on Food, European Commission: Opinion of the 
Scientific Committee on Food on the safety of the presence of safrole (1-allyl-3,4-
methylene dioxy benzene) in flavourings and other food ingredients with flavouring 
properties. (SCF/CS/FLAV/FLAVOUR/6 ADD3 Final).  
 
 WHO 2009. World Health Organization: WHO Food Additives Series: 60. Safety 
evaluation of certain food additives. The 69
th
 Meeting of Joint FAO/WHO Expert 
Committee on Food Additives.  
 
 
 
 
 73 
Appendix C 
Reference of Previous Laboratory Studies Using Safrole 
Studies on betel quid chewing were included in this chart as they gave the unique 
opportunity to study the effects of safrole injection in humans. The inflorescence of Piper 
betle contains 15.35 mg safrole when fresh, which metabolize to dihydroxychavicol and 
eugenol (both mentioned in the chart) (Chang et al., 2002). Betel quid chewing is vastly 
different from consuming sassafras products, both in the complexity and composition of 
material and in the mode of safrole absorption. Both products contain safrole, so we can 
observe similarities in physiological effects from a range of concentrations.  
Many studies quantify the presence of carcinogen- DNA adducts as a risk for 
cancer is influenced by the capability of a compound to form these covalent bonds. There 
is a correlation between the incidence of carcinogen-DNA adducts and the formation of 
carcinogenic tumors, but adducts do not predict the risk of cancer (Groopman & Skipper 
1991). 
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Table C.1: Review of studies using traditional or modern methods of preparation.  
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Table C.2: Review of studies using laboratory animals and bacterial studies to test the 
toxicity of safrole and derivatives.  
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h
em
 R
es
. 
T
o
x
ic
o
l.
 7
: 
4
4
3
-
4
5
0
. 
Y
ea
r 
1
9
6
1
 
1
9
8
5
 
1
9
7
7
 
1
9
9
4
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T
es
ti
n
g
 t
h
e 
th
eo
ry
 t
h
at
 s
af
ro
le
 u
n
d
er
g
o
es
 i
n
 v
iv
o
 
co
n
v
er
si
o
n
 t
o
 e
le
ct
ro
p
h
y
ll
ic
 a
ll
y
li
c 
an
d
 b
en
zy
li
c 
es
te
rs
 t
h
at
 a
re
 t
h
e 
tr
u
e 
ca
rc
in
o
g
en
s.
 1
'-
h
y
d
ro
x
y
sa
fr
o
le
 i
s 
th
e 
p
ri
m
ar
y
 m
et
ab
o
li
te
 o
f 
sa
fr
o
le
 a
n
d
 a
 p
ro
x
im
at
e 
ca
rc
in
o
g
en
, 
m
o
re
 s
o
 t
h
an
 
sa
fr
o
le
. 
 
S
h
o
w
ed
 1
'-
h
y
d
ro
x
y
sa
fr
o
le
 i
s 
m
o
re
 c
ar
ci
n
o
g
en
ic
 
th
an
 s
af
ro
le
 i
n
 a
d
u
lt
 m
al
e 
ra
ts
, 
al
m
o
st
 h
al
f 
o
f 
ra
ts
 
g
iv
en
 1
'-
h
y
d
ro
x
y
sa
fr
o
le
 d
ev
el
o
p
ed
 l
iv
er
 
ca
rc
in
o
m
as
 b
y
 8
 m
o
n
th
s 
v
er
su
s 
ra
ts
 g
iv
en
 s
af
ro
le
 
0
.0
4
%
 d
ev
el
o
p
in
g
 l
iv
er
 c
ar
ci
n
o
m
as
 b
y
 1
6
 
m
o
n
th
s.
 T
h
e 
ro
d
en
ts
 g
ai
n
ed
 w
ei
g
h
t 
m
o
re
 s
lo
w
ly
, 
b
u
t 
u
n
ti
l 
th
ey
 s
ta
rt
ed
 d
ev
el
o
p
in
g
 t
u
m
o
rs
, 
su
rv
iv
o
rs
h
ip
 w
as
 h
ig
h
. 
 
S
af
ro
le
 t
es
te
d
 p
o
si
ti
v
e 
fo
r 
S
is
te
r 
C
h
ro
m
at
id
 
E
x
ch
an
g
e 
as
sa
y
. 
 
S
h
o
w
ed
 t
h
at
 m
an
y
 o
f 
th
e 
co
m
p
o
u
n
d
s 
v
o
la
ti
li
ze
d
 
d
u
ri
n
g
 t
h
e 
in
cu
b
at
io
n
 p
er
io
d
. 
T
es
te
d
 t
h
e 
re
co
v
er
y
 
o
f 
th
e 
co
m
p
o
u
n
d
s 
fr
o
m
 h
o
u
se
fl
ie
s 
an
d
 m
ic
e.
  
9
0
 m
g
 w
as
 
in
je
ct
ed
 i
n
to
 
ra
ts
 o
r 
3
0
 
m
g
/1
0
0
 g
 b
o
d
y
 
w
ei
g
h
t 
R
at
s 
an
d
 m
ic
e:
 
fe
d
 v
ia
 d
ie
t 
co
n
c.
 o
f 
0
.5
%
, 
0
.4
%
, 
o
r 
0
.3
%
 
sa
fr
o
le
, 
0
.5
5
%
 
o
r 
0
.4
4
%
 1
'-
h
y
d
ro
x
y
sa
fr
o
le
 
fo
r 
8
.5
 t
o
 1
1
 
m
o
n
th
s 
    
S
af
ro
le
 
st
an
d
ar
d
 
S
af
ro
le
 
st
an
d
ar
d
 
  S
ta
n
d
ar
d
 
R
at
s 
(3
0
0
 
g
),
 
h
am
st
er
s,
 
an
d
 g
u
in
ea
 
p
ig
s.
 
C
D
 r
at
s 
(2
3
0
-2
6
0
 
g
) 
an
d
 C
D
-
1
 m
ic
e 
(2
7
-
2
9
 g
) 
In
 v
iv
o
 
m
am
m
al
ia
n
 c
el
l 
g
en
o
to
x
ic
it
y
 a
ss
ay
 
H
o
u
se
 f
ly
 
an
d
 m
al
e 
al
b
in
o
 m
ic
e 
B
o
rc
h
er
t,
 P
.,
 e
t 
al
. 
T
h
e 
m
et
ab
o
li
sm
 o
f 
th
e 
n
at
u
ra
ll
y
 
o
cc
u
rr
in
g
 h
ep
at
o
ca
rc
in
o
g
en
 
sa
fr
o
le
 t
o
 1
'-
h
y
d
ro
x
y
sa
fr
o
le
 
an
d
 t
h
e 
el
ec
tr
o
p
h
il
ic
 
re
ac
ti
v
it
y
 o
f 
1
'-
ac
et
o
x
y
sa
fr
o
le
. 
C
an
ce
r 
R
es
ea
rc
h
 3
3
: 
5
7
5
-5
8
9
. 
 
B
o
rc
h
es
t,
 P
.,
 e
t 
al
. 
1
'-
h
y
d
ro
x
y
sa
fr
o
le
, 
a 
p
ro
x
im
at
e 
ca
rc
in
o
g
en
ic
 m
et
ab
o
li
te
 o
f 
sa
fr
o
le
 i
n
 t
h
e 
ra
t 
an
d
 m
o
u
se
. 
C
an
ce
r 
R
es
. 
3
3
: 
5
9
0
- 
6
0
0
. 
B
ra
d
le
y
, 
M
.O
. 
M
ea
su
re
m
en
t 
o
f 
D
N
A
 s
in
g
le
-s
tr
an
d
 b
re
ak
s 
b
y
 a
lk
al
in
e 
el
u
ti
o
n
 i
n
 r
at
 
h
ep
at
o
cy
te
s.
 I
n
: 
A
sh
b
y
 a
n
d
 
d
e 
S
er
re
s 
(e
d
s)
. 
E
v
al
u
at
io
n
 
o
f 
S
h
o
rt
-t
er
m
 T
es
ts
 f
o
r 
C
ar
ci
n
o
g
en
s.
 E
ls
ev
ie
r,
 N
.Y
.,
 
3
5
3
-3
5
7
. 
C
as
id
a,
 J
. 
E
.,
 e
t 
al
. 
M
et
h
y
le
n
e-
C
1
4
-d
io
x
y
p
h
en
y
l 
co
m
p
o
u
n
d
s:
  
M
et
ab
o
li
sm
 i
n
 
re
la
ti
o
n
 t
o
 t
h
ei
r 
sy
n
er
g
is
ti
c 
ac
ti
o
n
. 
S
ci
en
ce
 1
5
3
(3
7
4
0
):
 
1
1
3
0
-1
1
3
3
 
1
9
7
3
 
1
9
7
3
 
1
9
8
5
 
1
9
6
6
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S
af
ro
le
 a
n
d
 s
ix
 d
er
iv
at
iv
es
 w
er
e 
te
st
ed
- 
th
e 
d
er
iv
at
iv
es
 p
ro
v
ed
 t
o
 b
e 
m
o
re
 c
y
to
to
x
ic
 t
o
 
h
u
m
an
 c
an
ce
r 
ce
ll
s 
th
an
 s
af
ro
le
. 
 
R
at
s 
w
er
e 
u
se
d
 t
o
 e
st
ab
li
sh
 a
 l
in
ea
r 
d
o
se
-
re
sp
o
n
se
 r
el
at
io
n
sh
ip
- 
fo
u
n
d
 t
h
at
 t
h
er
e 
w
as
 a
 
m
et
ab
o
li
c 
sa
tu
ra
ti
o
n
 b
et
w
ee
n
 1
5
0
 a
n
d
 3
0
0
 
m
g
/k
g
 i
n
 r
at
s.
 T
h
e 
sa
fr
o
le
 m
et
ab
o
li
te
s 
d
ih
y
d
ro
x
y
ch
av
ic
o
l 
an
d
 e
u
g
en
o
l 
w
er
e 
fo
u
n
d
 
in
 t
h
e 
u
ri
n
e 
o
f 
n
o
n
-b
et
el
 q
u
id
 c
h
ew
er
s,
 a
t 
th
e 
le
v
el
s 
o
f 
n
o
t 
d
et
ec
te
d
 t
o
 5
.4
 m
ic
ro
g
ra
m
s/
m
g
 
cr
ea
ti
n
in
e,
 p
ro
b
ab
ly
 d
u
e 
to
 s
p
ic
es
 i
n
 t
h
e 
d
ie
t.
  
L
iv
er
 w
ei
g
h
t 
in
cr
ea
se
d
 t
o
 2
0
%
 a
ft
er
 w
ee
k
 1
. 
L
iv
er
 w
ei
g
h
t 
co
n
ti
n
u
ed
 t
o
 i
n
cr
ea
se
 t
o
 6
0
%
 
m
o
re
 t
h
an
 t
h
e 
co
n
tr
o
l 
g
ro
u
p
 b
y
 w
ee
k
 8
 w
it
h
 
a 
d
ec
re
as
e 
in
 d
ru
g
 m
et
ab
o
li
zi
n
g
 e
n
zy
m
e 
ac
ti
v
it
y
. 
C
y
to
ch
ro
m
e 
P
-4
5
0
 w
as
 i
n
it
ia
ll
y
 
8
0
%
 h
ig
h
er
, 
b
u
t 
lo
w
er
ed
 t
o
 2
0
-3
0
%
 h
ig
h
er
 
af
te
r 
1
6
 w
ee
k
s.
 N
o
ti
ce
d
 e
n
la
rg
ed
 
ce
n
tr
il
o
b
u
la
r 
h
ep
at
o
cy
te
s,
 i
n
d
iv
id
u
al
 c
el
l 
n
ec
ro
si
s,
 a
n
d
 n
ec
ro
si
s 
o
f 
h
ep
at
o
cy
te
s.
 
U
se
d
 3
2
P
-p
o
st
la
b
el
in
g
 a
ss
ay
 t
h
at
 s
af
ro
le
 
fo
rm
s 
D
N
A
 a
d
d
u
ct
s,
 i
n
 t
u
rn
 i
n
d
u
ce
s 
si
st
er
 
ch
ro
m
at
id
 e
x
ch
an
g
es
 a
n
d
 c
h
ro
m
o
so
m
al
 
ab
er
ra
ti
o
n
s 
as
sa
y
s.
  
  R
at
s:
 0
, 
3
0
, 
7
5
, 
1
5
0
, 
3
0
0
 m
g
/k
g
. 
T
es
te
d
 u
ri
n
e 
o
f 
ra
ts
 a
n
d
 h
u
m
an
 
w
h
o
 c
h
ew
ed
 
q
u
id
 b
et
w
ee
n
 2
 
- 
1
0
0
 t
im
es
 a
 
d
ay
 
D
ie
t 
co
n
ta
in
in
g
 
0
.2
5
%
 (
w
/w
) 
sa
fr
o
le
 f
o
r 
8
5
 
w
ee
k
s,
 1
0
%
 
m
o
re
 s
af
ro
le
 
w
as
 i
n
it
ia
ll
y
 
ad
d
ed
 d
u
e 
to
 
v
o
la
ti
li
ty
 
0
.0
2
5
 t
o
 0
.2
 
m
g
/m
l 
S
af
ro
le
 
st
an
d
ar
d
 
S
af
ro
le
 
st
an
d
ar
d
 
S
af
ro
le
 
st
an
d
ar
d
 
S
af
ro
le
 
st
an
d
ar
d
 
B
re
as
t 
an
d
 
co
lo
re
ct
al
 
ca
n
ce
r 
ce
ll
 l
in
es
  
A
d
u
lt
 
m
al
e 
W
is
ta
r 
ra
ts
 a
n
d
 
h
u
m
an
 
u
ri
n
e 
 
F
em
al
e 
W
is
ta
r 
al
b
in
o
 r
at
s 
(8
0
-1
0
0
 
g
) 
C
h
in
es
e 
h
am
st
er
 
lu
n
g
 c
el
ls
 
C
at
al
án
, 
L
. 
E
.,
 e
t 
al
. 
S
y
n
th
es
is
 o
f 
N
in
e 
S
af
ro
le
 D
er
iv
at
iv
es
 a
n
d
 
T
h
ei
r 
A
n
ti
p
ro
li
fe
ra
ti
v
e 
A
ct
iv
it
y
 
T
o
w
ar
d
s 
H
u
m
an
 C
an
ce
r 
C
el
ls
. 
Jo
u
rn
al
 o
f 
th
e 
C
h
il
ea
n
 C
h
em
ic
al
 
S
o
ci
et
y
 5
5
: 
2
, 
2
1
9
-2
2
2
. 
 
C
h
an
g
, 
M
.J
.W
.,
 C
.Y
. 
K
o
, 
R
.F
. 
L
in
 &
 L
.L
. 
H
si
eh
. 
B
io
lo
g
ic
al
 
m
o
n
it
o
ri
n
g
 o
f 
en
v
ir
o
n
m
en
t 
ex
p
o
su
re
 t
o
 s
af
ro
le
 a
n
d
 t
h
e 
T
ai
w
an
es
e 
b
et
el
 q
u
id
 c
h
ew
in
g
. 
A
rc
h
. 
E
n
v
ir
o
n
. 
C
o
n
ta
m
. 
T
o
x
ic
o
l.
 
4
3
: 
4
3
2
–
4
3
7
. 
C
ra
m
p
to
n
, 
R
.F
.,
 e
t 
al
. 
L
o
n
g
-t
er
m
 
st
u
d
ie
s 
o
n
 c
h
em
ic
al
ly
 i
n
d
u
ce
d
 
li
v
er
 e
n
la
rg
em
en
t 
in
 t
h
e 
ra
t.
 I
I.
 
T
ra
n
si
en
t 
in
d
u
ct
io
n
 o
f 
m
ic
ro
so
m
al
 e
n
zy
m
es
 l
ea
d
in
g
 t
o
 
li
v
er
 d
am
ag
e 
an
d
 
n
o
d
u
la
rh
y
p
er
p
la
si
a 
p
ro
d
u
ce
d
 b
y
 
sa
fr
o
le
 a
n
d
 P
o
n
ce
au
 M
X
. 
T
o
x
ic
o
lo
g
y
 7
: 
3
0
7
-3
2
6
. 
D
ai
m
o
n
 H
.,
 S
. 
S
aw
ad
a,
 S
. 
A
sa
k
u
ra
 &
 F
. 
S
ag
am
i.
 A
n
al
y
si
s 
o
f 
cy
to
g
en
et
ic
 e
ff
ec
ts
 a
n
d
 D
N
A
 
ad
d
u
ct
 f
o
rm
at
io
n
 i
n
d
u
ce
d
 b
y
 
sa
fr
o
le
 i
n
 C
h
in
es
e 
h
am
st
er
 l
u
n
g
 
ce
ll
s.
 T
er
at
o
g
en
es
is
 
C
ar
ci
n
o
g
en
es
is
 M
u
ta
g
en
es
is
 
1
7
(1
):
 7
-1
8
. 
2
0
1
0
 
2
0
0
2
 
1
9
7
7
 
1
9
9
7
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N
o
 m
o
rt
al
it
y
. 
T
h
e 
si
n
g
le
 d
o
se
s 
d
id
 n
o
t 
in
d
u
ce
 
ch
ro
m
o
so
m
e 
ab
er
ra
ti
o
n
, 
b
u
t 
th
e 
re
p
ea
te
d
 
d
o
se
s 
in
cr
ea
se
d
 a
b
er
ra
n
t 
ce
ll
s 
in
 t
h
e 
li
v
er
. 
T
h
e 
si
n
g
le
 d
o
se
s 
at
 1
0
0
, 
2
5
0
 a
n
d
 5
0
0
 m
g
/k
g
 a
n
d
 
th
e 
re
p
ea
te
d
 d
o
se
s 
in
d
u
ce
d
 s
is
te
r 
ch
ro
m
at
id
 
ex
ch
an
g
es
. 
D
N
A
 a
d
d
u
ct
s 
w
er
e 
fo
u
n
d
 i
n
 t
h
e 
si
n
g
le
 d
o
se
s 
o
f 
1
0
 (
2
 a
d
d
u
ct
s)
 a
n
d
 1
0
0
, 
2
5
0
, 
&
 5
0
0
 (
4
 a
d
d
u
ct
s)
 m
g
/k
g
 w
h
il
e 
n
o
 a
d
d
u
ct
s 
w
er
e 
o
b
se
rv
ed
 i
n
 1
 m
g
/k
g
 
P
u
rp
o
se
 o
f 
th
is
 s
tu
d
y
 w
as
 t
o
 d
is
co
v
er
 t
h
e 
ac
ti
v
at
io
n
 o
r 
en
h
an
ce
m
en
t 
o
f 
sa
fr
o
le
 t
h
at
 t
es
ts
 
p
o
si
ti
v
es
 f
o
r 
th
e 
A
m
es
 t
es
t.
 S
af
ro
le
 t
es
te
d
 
p
o
si
ti
v
e 
u
si
n
g
 s
tr
ai
n
 T
A
 1
5
3
5
, 
ac
ti
v
at
ed
 b
y
 r
at
 
li
v
er
 i
n
je
ct
ed
 w
it
h
 s
af
ro
le
 i
n
 v
iv
o
. 
P
re
v
io
u
s 
st
u
d
ie
s 
te
st
ed
 s
af
ro
le
 w
it
h
o
u
t 
b
ei
n
g
 m
o
d
if
ie
d
 
an
d
 s
h
o
w
ed
 s
af
ro
le
 t
o
 b
e 
n
eg
at
iv
e 
in
 a
n
 A
m
es
 
te
st
. 
T
h
e 
1
'-
h
y
d
ro
x
y
 m
et
ab
o
li
te
s 
o
f 
b
o
th
 e
st
ra
g
o
le
 
an
d
 s
af
ro
le
 w
er
e 
fo
u
n
d
 t
o
 b
e 
m
o
re
 
ca
rc
in
o
g
en
ic
 t
h
an
 t
h
e 
p
ar
en
t 
co
m
p
o
u
n
d
s.
 5
9
%
 
o
f 
th
e 
m
ic
e 
g
iv
en
 1
'-
h
y
d
ro
x
y
sa
fr
o
le
 
d
ev
el
o
p
ed
 l
iv
er
 t
u
m
o
rs
. 
 
F
iv
e 
d
o
se
s 
o
f 
6
2
.5
, 
1
2
5
 o
r 
2
5
0
 m
g
/k
g
, 
si
n
g
le
 d
o
se
s 
o
f 
1
, 
1
0
, 
1
0
0
, 
2
5
0
, 
o
r 
5
0
0
 m
g
/k
g
 
v
ia
 s
to
m
ac
h
 
tu
b
e 
4
2
 m
g
/r
at
/d
ay
 
v
ia
 i
.p
. 
in
je
ct
io
n
 f
o
r 
th
re
e 
d
ay
s 
N
ew
b
o
rn
 m
ic
e:
 
to
ta
l 
o
f 
4
.4
3
 
m
ic
ro
m
o
le
s;
 9
-
1
2
 w
ee
k
 o
ld
 
m
ic
e:
 t
o
ta
l 
o
f 
5
.1
9
 
m
ic
ro
m
o
le
s,
 
v
ia
 s
e 
in
je
ct
io
n
 
S
af
ro
le
 
S
ta
n
d
ar
d
 
  S
af
ro
le
 
st
an
d
ar
d
, 
sy
n
th
es
iz
ed
 t
o
 1
'-
h
y
d
ro
x
y
 
sa
fr
o
le
 
R
at
 
(F
3
4
4
) 
m
o
d
el
 
A
d
u
lt
 
ra
ts
 
C
D
-1
 
m
ic
e,
 
n
ew
b
o
rn
 
(1
6
 g
) 
an
d
 9
-1
2
 
w
ee
k
 o
ld
 
(3
5
 g
) 
D
ai
m
o
n
, 
H
.,
 S
. 
S
aw
ad
a,
 S
. 
A
sa
k
u
ra
, 
an
d
 F
. 
S
ag
an
i.
 I
n
 v
iv
o
 
g
en
o
to
x
ic
it
y
 a
n
d
 D
N
A
 a
d
d
u
ct
 
le
v
el
s 
in
 t
h
e 
li
v
er
 o
f 
ra
ts
 t
re
at
ed
 
w
it
h
 s
af
ro
le
. 
C
ar
ci
n
o
g
en
es
is
 1
9
: 
1
4
1
-1
4
6
. 
D
o
ra
n
g
e,
 J
. 
L
. 
et
 a
l.
 C
o
m
p
ar
at
iv
e 
su
rv
ey
 o
f 
m
ic
ro
so
m
al
 a
ct
iv
at
io
n
 
sy
st
em
s 
fo
r 
m
u
ta
g
en
ic
 s
tu
d
ie
s 
o
f 
sa
fr
o
le
, 
M
u
ta
ti
o
n
 R
es
ea
rc
h
  
5
3
: 
1
7
9
-1
8
0
. 
D
ri
n
k
w
at
er
, 
N
. 
R
. 
et
 a
l.
 
H
ep
at
o
ca
rc
in
o
g
en
ic
it
y
 o
f 
es
tr
ag
o
le
 
(1
 a
ll
y
l-
4
-m
et
h
o
x
y
b
en
ze
n
e)
 a
n
d
 
1
'-
h
y
d
ro
x
y
es
tr
ag
o
le
 i
n
 t
h
e 
m
o
u
se
 
an
d
 m
u
ta
g
en
ic
it
y
 o
f 
1
'-
ac
et
o
x
y
es
tr
ag
o
le
 i
n
 b
ac
te
ri
a.
 J
. 
N
at
l.
 C
an
ce
r 
In
st
. 
5
7
: 
1
3
2
3
-1
3
3
1
. 
1
9
9
8
 
1
9
7
8
 
1
9
7
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S
af
ro
le
 r
ea
ct
s 
to
 f
o
rm
 a
 s
af
ro
le
 
m
et
ab
o
li
te
- 
cy
to
ch
ro
m
e 
P
-4
5
0
 
co
m
p
le
x
. 
 
D
o
m
in
an
t 
le
th
al
 a
ss
ay
: 
sa
fr
o
le
 t
es
te
d
 
n
eg
at
iv
e 
T
h
e 
b
il
e 
an
d
 u
ri
n
e 
sa
m
p
le
s 
sh
o
w
ed
 
sa
fr
o
le
 m
et
ab
o
li
ze
d
 i
n
to
 i
so
sa
fr
o
le
 
an
d
 d
ih
y
d
ro
sa
fr
o
le
. 
T
h
e 
sa
fr
o
le
 a
n
d
 
m
et
ab
o
li
te
s 
w
er
e 
sl
o
w
ly
 e
li
m
in
at
ed
 i
n
 
th
e 
b
il
e.
  
2
%
 (
w
/w
) 
v
ia
 
d
ie
t 
fo
r 
tw
o
 
w
ee
k
s.
  
  0
.0
4
 m
l 
v
ia
 
in
tr
av
en
o
u
s 
in
je
ct
io
n
 
S
af
ro
le
 
st
an
d
ar
d
 
  S
af
ro
le
 
st
an
d
ar
d
 
M
al
e 
S
p
ra
g
u
e-
D
aw
le
y
 
ra
ts
 (
2
0
0
 
g
) 
S
w
is
s 
m
ic
e 
8
-1
0
 
w
ee
k
s 
o
ld
 
S
p
ra
g
u
e-
D
aw
le
y
 
m
ic
e 
(3
5
0
 
g
) 
E
lc
o
m
b
e,
 C
. 
R
. 
et
 a
l.
 S
tu
d
ie
s 
o
n
 
th
e 
in
te
ra
ct
io
n
 o
f 
sa
fr
o
le
 w
it
h
 r
at
 
h
ep
at
ic
 m
ic
ro
so
m
es
. 
B
io
ch
em
. 
P
h
ar
m
ac
o
l.
 2
4
: 
1
4
2
7
-1
4
3
3
. 
E
p
st
ei
n
, 
S
.S
.,
 e
t 
al
. 
D
et
ec
ti
o
n
 o
f 
ch
em
ic
al
 m
u
ta
g
en
s 
b
y
 t
h
e 
d
o
m
in
an
t 
le
th
al
 a
ss
ay
 i
n
 t
h
e 
m
o
u
se
. 
T
o
x
ic
o
lo
g
y
 a
n
d
 A
p
p
li
ed
 
P
h
ar
m
ac
o
lo
g
y
 2
3
: 
2
8
8
- 
3
2
5
. 
F
is
h
b
ei
n
, 
L
. 
et
 a
l.
 T
h
in
-l
ay
er
 
ch
ro
m
at
o
g
ra
p
h
y
 o
f 
ra
t 
b
il
e 
an
d
 
u
ri
n
e 
fo
ll
o
w
in
g
 i
n
tr
av
en
o
u
s 
ad
m
in
is
tr
at
io
n
 o
f 
sa
fr
o
le
, 
is
o
sa
fr
o
le
, 
an
d
 d
ih
y
d
ro
sa
fr
o
le
. 
J.
 
C
h
ro
m
at
o
g
. 
2
9
: 
2
6
7
-2
7
3
. 
1
9
7
5
 
1
9
7
2
 
1
9
6
7
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T
h
e 
sa
fr
o
le
 h
ad
 n
o
 e
ff
ec
t 
o
n
 
m
ic
ro
so
m
al
 e
n
zy
m
e 
ac
ti
v
it
y
. 
 
S
af
ro
le
 t
es
te
d
 n
eg
at
iv
e
 
S
af
ro
le
 w
as
 n
eu
tr
al
 o
r 
w
ea
k
ly
 p
o
si
ti
v
e
 
E
x
am
in
ed
 D
N
A
 u
si
n
g
 3
2
P
-p
o
st
la
b
el
in
g
 
as
sa
y
 a
t 
0
.5
, 
1
, 
2
, 
3
, 
7
, 
1
5
, 
an
d
 3
0
 d
ay
s.
 
S
h
o
w
ed
 a
 l
in
ea
r 
re
sp
o
n
se
 o
f 
sa
fr
o
le
-
D
N
A
 a
d
d
u
ct
s,
 r
ea
ch
in
g
 a
 t
h
re
sh
o
ld
 a
t 
th
e 
1
0
 m
g
 d
o
se
, 
w
h
er
e 
th
e 
ti
ss
u
e 
co
u
ld
 
b
e 
sa
tu
ra
te
d
 a
n
d
 t
h
e 
el
im
in
at
io
n
 o
f 
th
e 
co
m
p
o
u
n
d
 w
o
u
ld
 o
cc
u
r 
m
o
re
 s
lo
w
ly
. 
 
1
0
 m
g
/k
g
 o
n
e 
ti
m
e 
d
o
se
 o
f 
sa
fr
o
le
 v
ia
 i
.p
. 
in
je
ct
io
n
 
    O
n
e 
d
o
se
 o
f 
0
.0
0
1
, 
0
.0
1
, 
0
.1
, 
1
.0
, 
an
d
 1
0
.0
 
m
g
/m
o
u
se
 o
r 
0
.0
4
, 
0
.4
, 
4
, 
4
0
, 
o
r 
4
0
0
 m
g
/k
g
 b
w
 
S
af
ro
le
 
st
an
d
ar
d
 
    S
af
ro
le
 
st
an
d
ar
d
 
M
al
e 
S
w
is
s 
A
lb
in
o
 
m
ic
e 
(2
0
-
2
5
 g
) 
B
o
n
e-
m
ar
ro
w
 
m
ic
ro
n
u
cl
eu
s 
as
sa
y
 
In
 v
it
ro
 
S
al
m
o
n
el
l
a 
re
v
er
se
 
m
u
ta
ti
o
n
 
as
sa
y
 
(A
m
es
 
te
st
) 
F
em
al
e 
C
D
-1
 
m
ic
e 
(2
5
 
g
) 
F
ri
ed
m
an
, 
M
. 
A
.,
 E
. 
A
rn
o
ld
, 
Y
. 
B
is
h
o
p
, 
an
d
 S
.S
. 
E
p
st
ei
n
. 
A
d
d
it
iv
e 
an
d
 s
y
n
er
g
is
ti
c 
in
h
ib
it
io
n
 o
f 
m
am
m
al
ia
n
 
m
ic
ro
so
m
al
 e
n
zy
m
e 
fu
n
ct
io
n
s 
b
y
 p
ip
er
o
n
y
l 
b
u
to
x
id
e,
 s
af
ro
le
 
an
d
 o
th
er
 m
et
h
y
le
n
ed
io
x
y
p
h
en
y
l 
d
er
iv
at
iv
es
. 
E
x
p
er
ie
n
ti
a 
2
7
: 
1
0
5
2
-1
0
5
4
. 
 
G
o
ck
e,
 E
.,
 M
.T
. 
K
in
g
, 
K
. 
E
ck
ar
d
t,
 a
n
d
 D
.W
il
d
. 
M
u
ta
g
en
ic
it
y
 o
f 
co
sm
et
ic
s 
in
g
re
d
ie
n
ts
 l
ic
en
se
d
 b
y
 t
h
e 
E
u
ro
p
ea
n
 C
o
m
m
u
n
it
y
. 
M
u
ta
t.
 
R
es
. 
9
0
: 
9
1
-1
0
9
. 
G
re
en
, 
N
.R
. 
an
d
 S
av
ag
e,
 J
.R
.,
. 
S
cr
ee
n
in
g
 o
f 
sa
fr
o
le
, 
eu
g
en
o
l,
 
th
ei
r 
n
in
h
y
d
ri
n
 p
o
si
ti
v
e 
m
et
ab
o
li
te
s 
an
d
 s
el
ec
te
d
 
se
co
n
d
ar
y
 a
m
in
es
 f
o
r 
p
o
te
n
ti
al
 
m
u
ta
g
en
ic
it
y
. 
M
u
ta
ti
o
n
 
R
es
ea
rc
h
, 
5
7
, 
1
1
5
- 
1
2
1
. 
G
u
p
ta
, 
K
.P
.,
 K
.L
. 
v
an
 G
o
le
n
, 
K
.L
. 
P
u
tm
an
 &
 K
. 
R
an
d
er
at
h
. 
F
o
rm
at
io
n
 a
n
d
 p
er
si
st
en
ce
 o
f 
sa
fr
o
le
-D
N
A
 a
d
d
u
ct
s 
o
v
er
 a
 
1
0
,0
0
0
-f
o
ld
 d
o
se
 r
an
g
e 
in
 m
o
u
se
 
li
v
er
. 
C
ar
ci
n
o
g
en
es
is
 1
4
 (
8
):
 
1
5
1
7
–
1
5
2
1
. 
1
9
7
1
 
1
9
8
1
 
1
9
7
8
 
1
9
9
3
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T
h
e 
ra
ts
 f
ee
d
 1
0
,0
0
0
 p
p
m
 d
ie
d
 a
ft
e
r 
6
2
 w
ee
k
s,
 
an
d
 t
h
e 
re
st
 e
x
p
er
ie
n
ce
d
 g
ro
w
th
 r
et
ar
d
at
io
n
, 
in
cr
ea
se
d
 m
o
rt
al
it
y
 i
n
 t
h
e 
m
al
es
 (
at
 5
0
0
0
p
p
m
),
 
li
v
er
 e
n
la
rg
em
en
t 
w
it
h
 t
u
m
o
r 
m
as
se
s 
an
d
 
n
o
d
u
le
s,
 m
il
d
 h
y
p
er
p
la
si
a 
o
f 
th
y
ro
id
, 
an
d
 
in
cr
ea
se
 o
f 
ch
ro
n
ic
 n
ep
h
ri
ti
s 
in
 t
h
e 
k
id
n
ey
. 
T
h
e 
d
o
g
s 
ex
p
er
ie
n
ce
d
 l
iv
er
 e
n
la
rg
em
en
t 
an
d
 n
o
d
u
le
s 
at
 t
h
e 
2
0
 m
g
/k
g
 d
o
se
 a
n
d
 l
iv
er
 d
am
ag
e 
b
y
 f
o
ca
l 
n
ec
ro
si
s,
 b
il
e
-d
u
ct
 p
ro
li
fe
ra
ti
o
n
, 
fa
tt
y
 
m
et
am
o
rp
h
o
si
s,
 a
n
d
 o
th
er
 c
h
an
g
es
 a
t 
th
e 
5
 
m
g
/k
g
 d
o
se
. 
A
t 
7
5
0
 m
g
/k
g
, 
9
 o
u
t 
o
f 
1
0
 r
at
s 
d
ie
d
 a
t 
1
9
 d
ay
s,
 
at
 5
0
0
 m
g
/k
g
, 
1
 o
f 
1
0
 r
at
s 
d
ie
d
 a
ft
er
 4
6
 d
ay
s,
 
an
d
 a
t 
2
5
0
 m
g
/k
g
, 
n
o
 r
at
s 
d
ie
d
 b
u
t 
th
ey
 
ex
p
er
ie
n
ce
d
 l
iv
er
 e
n
la
rg
em
en
t 
an
d
 f
o
ca
l 
n
ec
ro
si
s.
 N
o
 e
v
id
en
ce
 o
f 
to
x
ic
it
y
 f
o
r 
is
o
sa
fr
o
le
. 
D
ih
y
d
ro
sa
fr
o
le
 w
as
 f
o
u
n
d
 t
o
 b
e 
a 
es
o
p
h
ag
ea
l 
ca
rc
in
o
g
en
. 
M
ic
e 
sh
o
w
ed
 s
im
il
ar
 l
iv
er
 c
h
an
g
es
 
as
 f
o
u
n
d
 i
n
 t
h
e 
ra
ts
. 
 
T
h
e 
ra
ts
 r
ec
ei
v
in
g
 h
ig
h
 p
ro
te
in
 d
ie
ts
 (
3
0
%
 
p
ro
te
in
),
 t
h
e 
li
v
er
 a
p
p
ea
re
d
 n
o
rm
al
 c
o
m
p
ar
ed
 t
o
 
th
e 
co
n
tr
o
l 
w
h
il
e 
o
th
er
 d
ie
ts
 w
it
h
 l
o
w
er
 p
ro
te
in
 
h
ad
 s
m
al
le
r 
li
v
er
s 
w
h
en
 f
ed
 w
it
h
 s
af
ro
le
. 
T
h
e 
sa
fr
o
le
 s
p
ik
ed
 d
ie
ts
 r
es
u
lt
ed
 i
n
 l
iv
er
s 
w
it
h
 n
o
 f
at
 
p
re
se
n
t.
 R
at
s 
g
iv
en
 s
af
ro
le
 l
iv
ed
 l
o
n
g
er
 t
h
an
 t
h
e 
co
n
tr
o
l,
 b
u
t 
th
er
ef
o
re
 h
ad
 a
 h
ig
h
er
 l
ev
el
 o
f 
h
ep
at
o
m
as
. 
R
at
s,
 a
d
u
lt
: 
1
0
0
0
, 
2
5
0
0
, 
5
0
0
0
, 
an
d
 
1
0
,0
0
0
 p
p
m
 
fo
r 
tw
o
 y
ea
rs
; 
D
o
g
s 
(2
M
, 
2
F
):
 5
 a
n
d
 2
0
 
m
g
/k
g
 f
o
r 
6
 
y
ea
rs
 
R
at
s,
 a
d
u
lt
: 
2
5
0
, 
5
0
0
, 
7
5
0
 
m
g
/k
g
/d
ay
 
fo
r 
1
0
5
 d
ay
s;
 
M
ic
e:
 2
5
0
 
an
d
 5
0
0
 
m
g
/k
g
 f
o
r 
6
0
 
d
ay
s 
0
.5
%
 s
af
ro
le
 
v
ia
 d
ie
t 
fo
r 
fi
v
e 
d
ie
ts
 
w
it
h
 v
ar
y
in
g
 
le
v
el
s 
o
f 
p
ro
te
in
, 
fa
t,
 
ca
rb
o
h
y
d
ra
te
s,
 a
n
d
 s
al
ts
. 
S
af
ro
le
 
st
an
d
ar
d
 
  S
af
ro
le
 
st
an
d
ar
d
 
O
sb
o
u
rn
e-
M
en
d
el
 
ra
ts
 a
n
d
 
p
u
re
-
b
re
ed
 
b
ea
g
le
 
d
o
g
s 
O
sb
o
u
rn
e-
M
en
d
el
 
ra
ts
 a
n
d
 
S
w
is
s 
m
ic
e
 
O
sb
o
u
rn
e-
M
en
d
el
 
m
al
e 
ra
ts
 
(1
1
4
 g
) 
H
ag
an
, 
E
.C
.,
 W
.H
. 
H
an
se
n
, 
O
.G
. 
F
it
zh
u
g
h
, 
P
.M
. 
Je
n
n
er
, 
W
.I
. 
Jo
n
es
, 
J.
M
, 
T
ay
lo
r,
 E
.L
. 
L
o
n
g
, 
A
.A
. 
N
el
so
n
, 
an
d
 J
.B
. 
B
ro
u
w
er
. 
F
o
o
d
 
fl
av
o
u
ri
n
g
s 
an
d
 
co
m
p
o
u
n
d
s 
o
f 
re
la
te
d
 
st
ru
ct
u
re
. 
II
. 
S
u
b
ac
u
te
 a
n
d
 
ch
ro
n
ic
 t
o
x
ic
it
y
. 
F
o
o
d
 
C
o
sm
. 
T
o
x
ic
o
l.
 5
: 
1
4
1
-
1
5
7
. 
H
ag
an
, 
E
.C
.,
 P
. 
M
. 
Je
n
n
er
, 
W
. 
I.
 J
o
n
es
, 
O
. 
G
. 
F
it
zh
u
g
h
, 
E
. 
L
. 
L
o
n
g
, 
J.
 G
. 
B
ro
u
w
er
, 
W
. 
W
el
fa
re
. 
T
o
x
ic
 p
ro
p
er
ti
es
 o
f 
co
m
p
o
u
n
d
s 
re
la
te
d
 t
o
 
sa
fr
o
le
. 
T
o
x
ic
o
lo
g
y
 a
n
d
 
A
p
p
li
ed
 P
h
ar
m
ac
o
lo
g
y
 
7
(1
):
 1
8
-2
4
. 
 
H
o
m
b
u
rg
er
, 
F
.,
 P
.D
. 
B
o
g
d
o
n
o
ff
 a
n
d
 T
.F
. 
K
el
le
y
. 
In
fl
u
en
ce
 o
f 
d
ie
t 
o
n
 c
h
ro
n
ic
 o
ra
l 
to
x
ic
it
y
 o
f 
sa
fr
o
le
 a
n
d
 b
u
tt
er
 y
el
lo
w
 
in
 r
at
s.
  
P
ro
ce
ed
in
g
s 
o
f 
th
e 
S
o
ci
et
y
 f
o
r 
E
x
p
er
im
en
ta
l 
B
io
lo
g
y
 a
n
d
 M
ed
ic
in
e 
1
1
9
 
(4
):
 1
1
0
6
-1
1
1
0
. 
1
9
6
7
 
1
9
6
5
 
1
9
6
5
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S
af
ro
le
 t
es
te
d
 p
o
si
ti
v
e 
fo
r 
g
en
o
to
x
ic
it
y
 a
ct
iv
it
y
, 
at
 a
 h
ig
h
er
 d
o
se
 
th
an
 p
re
v
io
u
s 
st
u
d
ie
s 
(P
ro
b
st
 e
t 
al
. 
1
9
8
1
) 
th
at
 t
es
te
d
 s
m
al
l 
d
o
se
s.
  
B
o
th
 i
n
se
ct
s 
sh
o
w
ed
 s
u
sc
ep
ti
b
il
it
y
 t
o
 
th
e 
fu
m
ig
an
t 
to
x
ic
it
y
 o
f 
sa
fr
o
le
. 
T
h
er
e 
w
as
 s
li
g
h
t 
fe
ed
in
g
 d
et
er
re
n
ce
 a
g
ai
n
st
 
S
. 
ze
a
m
a
is
 d
u
e 
to
 r
ed
u
ce
d
 f
o
o
d
 
co
n
su
m
p
ti
o
n
 a
n
d
 n
o
 d
et
er
re
n
ce
 f
o
r 
T
. 
ca
st
a
n
eu
m
. 
 
S
af
ro
le
 d
id
 n
o
t 
ef
fe
ct
 g
ro
w
th
 o
f 
A
. 
a
ct
in
o
m
yc
et
em
co
m
it
a
n
s 
o
r 
S
. 
m
u
ta
n
s,
 
b
u
t 
d
id
 d
ec
re
as
e 
th
e 
g
ro
w
th
 o
f 
E
. 
co
li
. 
S
af
ro
le
 r
ed
u
ce
s 
th
e 
re
le
as
e 
o
f 
su
p
er
o
x
id
e 
an
io
n
, 
b
u
t 
n
o
t 
th
ro
u
g
h
 a
 
d
ir
ec
t 
k
il
li
n
g
 o
f 
n
eu
tr
o
p
h
il
s,
 o
r 
a 
h
o
st
 
d
ef
en
se
 m
ec
h
an
is
m
. 
S
af
ro
le
 r
ed
u
ce
d
 
an
ti
m
ic
ro
b
ia
l 
ac
ti
v
it
y
 b
u
t 
d
id
 n
o
t 
d
em
o
n
st
ra
te
 c
y
to
to
x
ic
it
y
. 
 
1
0
^
-3
 M
 s
af
ro
le
 
fo
r 
a 
u
n
sc
h
ed
u
le
d
 
D
N
A
 s
y
n
th
es
is
 
as
sa
y
s 
in
 
cu
lt
u
re
d
 r
at
 
h
ep
at
o
cy
te
s.
  
F
u
m
ig
an
t 
st
u
d
y
 
at
 0
.9
 m
g
/c
m
^
3
 
an
d
 c
o
n
ta
ct
 
to
x
ic
it
y
 s
tu
d
y
 a
t 
2
.0
4
-1
6
.2
 m
g
/g
 
o
f 
fo
o
d
. 
 
5
 m
M
 a
n
d
 1
0
 
m
M
 
S
af
ro
le
 
st
an
d
ar
d
 
S
af
ro
le
 
st
an
d
ar
d
 
S
af
ro
le
 
st
an
d
ar
d
 
M
al
e 
F
is
ch
er
 
3
4
4
 r
at
s.
  
S
it
o
p
h
il
u
s 
ze
a
m
a
is
 a
d
u
lt
s 
an
d
 T
ri
b
o
li
u
m
 
ca
st
a
n
eu
m
 
ad
u
lt
s 
an
d
 
la
rv
ae
 
O
ra
l 
p
at
h
o
g
en
s 
in
cl
u
d
in
g
 
A
ct
in
o
b
a
ci
ll
u
s 
a
ct
in
o
m
yc
et
em
co
m
it
a
n
s,
 
S
tr
ep
to
co
cc
u
s 
m
u
ta
n
s,
  
an
d
 
P
o
ry
p
h
yr
o
m
o
n
a
s 
g
in
g
iv
a
li
s 
H
o
w
es
, 
J.
A
.,
 V
.S
.W
. 
C
h
an
, 
an
d
 J
. 
C
al
d
w
el
l.
 S
tr
u
ct
u
re
-
sp
ec
if
ic
it
y
 o
f 
th
e 
g
en
o
to
x
ic
it
y
 
o
f 
so
m
e 
n
at
u
ra
ll
y
 o
cc
u
rr
in
g
 
al
k
en
y
l-
b
en
ze
n
es
 d
et
er
m
in
ed
 
b
y
 t
h
e 
u
n
sc
h
ed
u
le
d
 D
N
A
 
sy
n
th
es
is
 a
ss
ay
s 
in
 r
at
 
h
ep
at
o
cy
te
s.
 F
o
o
d
 C
h
em
. 
T
o
x
ic
o
l.
 2
8
: 
5
3
7
-5
4
2
. 
H
u
an
g
, 
Y
. 
H
o
 S
H
, 
K
in
i 
R
M
. 
B
io
ac
ti
v
it
ie
s 
o
f 
sa
fr
o
le
 a
n
d
 
is
o
sa
fr
o
le
 o
n
 S
it
o
p
h
il
u
s 
ze
a
m
a
is
 (
C
o
le
o
p
te
ra
: 
C
u
rc
u
li
o
n
id
ae
) 
an
d
 T
ri
b
o
li
u
m
 
ca
st
a
n
eu
m
 (
C
o
le
o
p
te
ra
: 
T
en
eb
ri
o
n
id
ae
).
 J
o
u
rn
al
 o
f 
E
co
n
o
m
ic
 E
n
to
m
o
lo
g
y
 9
2
: 
6
7
6
-6
8
3
. 
H
u
n
g
, 
S
.-
L
.,
 Y
.-
L
. 
C
h
en
, 
an
d
 
Y
.-
T
. 
C
h
en
. 
E
ff
ec
ts
 o
f 
sa
fr
o
le
 
o
n
 t
h
e 
d
ef
en
si
v
e 
fu
n
ct
io
n
s 
o
f 
h
u
m
an
 n
eu
tr
o
p
h
il
s.
 J
o
u
rn
al
 o
f 
P
er
io
d
o
n
ta
l 
R
es
ea
rc
h
 3
8
: 
1
3
0
–
1
3
4
. 
1
9
9
0
 
1
9
9
9
 
2
0
0
3
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L
iv
er
-c
el
l 
tu
m
o
rs
 f
o
u
n
d
 i
n
 1
4
 o
f 
3
4
 m
al
es
 a
n
d
 3
2
 o
f 
3
3
 f
em
al
es
. 
S
af
ro
le
 t
es
te
d
 p
o
si
ti
v
e 
 
E
st
ab
li
sh
ed
 a
cu
te
 t
o
x
ic
it
y
 a
t 
th
es
e 
co
n
ce
n
tr
at
io
n
s.
 
H
y
b
ri
d
 m
ic
e,
 7
 
d
ay
s 
o
ld
: 
4
6
4
 
m
g
/k
g
 o
v
er
 2
1
 
d
ay
s 
v
ia
 
st
o
m
ac
h
 t
u
b
e,
 
th
en
 1
2
6
5
 
m
g
/k
g
 o
v
er
 8
2
 
w
ee
k
s 
v
ia
 d
ie
t 
  1
9
5
0
 m
g
/k
g
 b
w
 
fo
r 
ra
ts
 a
n
d
 
2
3
5
0
 m
g
/k
g
 f
o
r 
m
ic
e
 
S
af
ro
le
 
st
an
d
ar
d
 
    
H
y
b
ri
d
 m
ic
e 
fr
o
m
 C
5
7
B
L
/6
 
(f
em
al
e)
 a
n
d
 
C
3
H
/A
n
f 
o
r 
A
K
R
 (
m
al
e)
 
st
ra
in
s 
In
 v
iv
o
 
m
am
m
al
ia
n
 
ce
ll
 
g
en
o
to
x
ic
it
y
 
as
sa
y
: 
ch
ro
m
o
so
m
al
 
ab
er
ra
ti
o
n
s 
R
at
 a
n
d
 m
ic
e 
In
n
es
, 
J.
R
.,
 B
.M
. 
U
ll
an
d
, 
M
.G
. 
V
al
er
io
, 
L
. 
P
et
ru
ce
ll
i,
 L
. 
F
is
h
b
ei
n
, 
E
.R
. 
H
as
t,
 
A
.J
. 
P
al
lo
ta
, 
R
.R
. 
B
at
es
, 
H
.L
. 
F
al
k
, 
L
.L
. 
G
ar
t,
 M
. 
K
le
in
, 
I.
 M
it
ch
el
l,
 a
n
d
 J
. 
P
et
er
. 
B
io
as
sa
y
 o
f 
p
es
ti
ci
d
es
 a
n
d
 i
n
d
u
st
ri
al
 
ch
em
ic
al
s 
fo
r 
tu
m
o
ri
g
en
ic
it
y
 i
n
 m
ic
e:
 a
 
p
re
li
m
in
ar
y
 n
o
te
. 
J.
 N
at
l.
 C
an
ce
r 
In
st
. 
4
2
: 
1
1
0
1
-1
1
1
4
. 
Is
h
id
at
e,
 M
. 
an
d
 T
. 
S
o
fu
n
i.
 T
h
e 
in
 v
it
ro
 
ch
ro
m
o
so
m
al
 a
b
er
ra
ti
o
n
 t
es
t 
u
si
n
g
 
C
h
in
es
e 
h
am
st
er
 l
u
n
g
 (
C
H
L
) 
fi
b
ro
b
la
st
 
ce
ll
s 
in
 c
u
lt
u
re
. 
In
: 
A
sh
b
y
 a
n
d
 d
e 
S
er
re
s 
(e
d
s)
. 
E
v
al
u
at
io
n
 o
f 
S
h
o
rt
-t
er
m
 T
es
ts
 
fo
r 
ca
rc
in
o
g
en
s.
 E
ls
ev
ie
r,
 N
.Y
.:
 4
2
7
-
4
3
2
. 
Je
n
n
er
, 
P
.M
.,
 E
.C
. 
H
ag
an
, 
J.
M
. 
T
ay
lo
r,
 
E
.L
. 
C
o
o
k
, 
an
d
 O
.G
. 
F
it
zh
u
g
h
. 
F
o
o
d
 
fl
av
o
u
ri
n
g
s 
an
d
 c
o
m
p
o
u
n
d
s 
o
f 
re
la
te
d
 
st
ru
ct
u
re
s.
 I
. 
A
cu
te
 O
ra
l 
T
o
x
ic
it
y
. 
F
o
o
d
 
C
o
sm
. 
T
o
x
ic
o
l.
 2
: 
3
2
7
-3
4
3
. 
1
9
6
9
 
1
9
8
5
 
1
9
6
4
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F
o
u
n
d
 t
h
e 
fo
rm
at
io
n
 o
f 
1
'-
h
y
d
ro
x
y
sa
fr
o
le
 
in
 t
h
e 
h
u
m
an
 l
iv
er
 m
ic
ro
so
m
es
. 
V
ar
io
u
s 
h
u
m
an
 c
y
to
ch
ro
m
e 
P
4
5
0
 e
n
zy
m
es
 
m
et
ab
o
li
ze
 s
af
ro
le
, 
in
cl
u
d
in
g
 e
n
zy
m
es
 
P
4
5
0
 2
C
9
*
1
, 
P
4
5
0
 2
A
6
, 
P
4
5
0
 2
D
6
*
1
, 
an
d
 
P
4
5
0
 2
E
1
. 
 
B
o
th
 d
o
se
s 
ex
p
er
ie
n
ce
d
 d
ec
re
as
ed
 b
o
d
y
 
w
ei
g
h
t 
g
ai
n
, 
li
v
er
 e
n
la
rg
em
en
t 
in
 t
h
e 
m
al
es
 
an
d
 f
em
al
es
 (
0
.5
%
 g
ro
u
p
 o
n
ly
),
 a
n
d
 s
in
g
le
 
ce
ll
 n
ec
ro
si
s.
 M
al
e 
ra
ts
 e
x
p
er
ie
n
ce
d
 
tu
b
u
la
r 
h
y
al
in
e 
d
ro
p
le
ts
, 
tu
b
u
la
r 
re
g
en
er
at
io
n
, 
g
ra
n
u
la
r 
ca
st
, 
p
el
v
ic
 
ca
lc
if
ic
at
io
n
, 
an
d
 i
n
te
rs
ti
ti
al
 c
el
l 
in
fi
lt
ra
ti
o
n
 i
n
 t
h
e 
k
id
n
ey
s.
  
T
h
e 
m
aj
o
r 
m
et
ab
o
li
c 
p
at
h
w
ay
 f
o
r 
sa
fr
o
le
 i
s 
cl
ea
v
ag
e 
o
f 
th
e 
m
et
h
y
le
n
ed
io
x
y
p
h
en
y
l 
m
o
ie
ty
 a
s 
w
el
l 
as
 e
x
p
ir
at
io
n
 o
f 
ca
rb
o
n
 
d
io
x
id
e 
fr
o
m
 t
h
e 
m
et
h
y
le
n
e 
ca
rb
o
n
. 
M
et
ab
o
li
sm
 o
f 
sa
fr
o
le
, 
(w
h
ic
h
 i
s 
v
o
la
ti
le
) 
re
su
lt
ed
 i
n
 l
es
s 
v
o
la
ti
le
, 
m
o
re
 p
o
la
r,
 a
n
d
 
et
h
er
-s
o
lu
b
le
 m
et
ab
o
li
te
s.
 F
o
u
n
d
 t
h
e 
m
et
ab
o
li
te
s 
o
f 
sa
fr
o
le
 w
er
e 
m
o
re
 v
o
la
ti
le
. 
 
T
h
e 
sa
fr
o
le
-f
re
e 
sa
ss
af
ra
s 
ex
tr
ac
t 
p
ro
d
u
ce
d
 
lo
ca
l 
tu
m
o
rs
 i
n
 6
6
%
 o
f 
th
e 
ra
ts
, 
th
o
u
g
h
 
st
u
d
y
 d
o
es
 n
o
t 
in
d
ic
at
ed
 i
f 
th
e 
sa
m
p
le
s 
w
er
e 
te
st
ed
 f
o
r 
sa
fr
o
le
 l
ev
el
s 
p
ri
o
r 
to
 
in
je
ct
io
n
. 
 
  R
at
s:
 6
9
.1
 
(0
.1
%
 i
n
 
d
ie
t)
 a
n
d
 
2
7
5
.6
 
(0
.5
%
) 
m
g
/k
g
/d
ay
 
fo
r 
1
3
 
w
ee
k
s 
M
ic
e:
 5
 
m
ic
ro
m
o
le
s/
k
g
 b
w
; 
ra
ts
 &
 
h
am
st
er
s:
 
1
0
 
m
ic
ro
m
o
le
s/
k
g
 b
w
 
R
at
s:
 1
5
 
m
g
 v
ia
 s
.c
. 
in
je
ct
io
n
 
fo
r 
7
8
 
w
ee
k
s 
S
af
ro
le
 
st
an
d
ar
d
 
S
af
ro
le
 
st
an
d
ar
d
 
S
af
ro
le
 
st
an
d
ar
d
 
S
as
sa
fr
as
 r
o
o
t 
b
ar
k
, 
ex
tr
ac
te
d
 w
it
h
 
p
et
ro
le
u
m
 
et
h
er
, 
m
et
h
y
le
n
e 
ch
lo
ri
d
e,
 a
n
d
 
et
h
an
o
l 
H
u
m
an
 
cy
to
ch
ro
m
e 
P
4
5
0
 e
n
zy
m
es
 
an
d
 
m
ic
ro
so
m
es
 
fr
o
m
 l
iv
er
 
ce
ll
s 
li
n
es
 
M
al
e 
an
d
 
F
em
al
e 
F
3
4
4
 
g
p
t 
d
el
ta
 r
at
s 
M
al
e 
S
w
is
s-
W
eb
st
er
 m
ic
e 
(1
8
-2
0
 g
),
 
m
al
e 
S
p
ra
g
u
e-
D
aw
le
y
 r
at
s 
(1
5
0
-1
7
0
 g
),
 
m
al
e 
h
am
st
er
 
(1
8
0
-2
0
0
 g
) 
N
IH
 B
la
ck
 
ra
ts
, 
1
-2
 
m
o
n
th
 o
ld
 
Je
u
ri
ss
en
, 
S
. 
M
. 
F
. 
et
 a
l.
 H
u
m
an
 
C
y
to
ch
ro
m
e 
P
4
5
0
 E
n
zy
m
e 
S
p
ec
if
ic
it
y
 f
o
r 
B
io
ac
ti
v
at
io
n
 o
f 
S
af
ro
le
 t
o
 t
h
e 
P
ro
x
im
at
e 
C
ar
ci
n
o
g
en
 1
-H
y
d
ro
x
y
sa
fr
o
le
. 
C
h
em
ic
al
 R
es
ea
rc
h
 i
n
 
T
o
x
ic
o
lo
g
y
. 
1
7
 (
9
):
 1
2
4
5
-1
2
5
0
. 
Ji
n
, 
M
.,
 A
. 
K
ij
m
a,
 Y
. 
S
u
zu
k
i,
 D
. 
H
ib
i,
 T
. 
In
o
u
e,
 Y
. 
Is
h
ii
, 
T
. 
N
o
h
m
i,
 A
. 
N
is
h
ik
aw
a,
 K
. 
O
g
aw
a,
 T
. 
U
m
en
u
ra
. 
C
o
m
p
re
h
en
si
v
e 
to
x
ic
it
y
 s
tu
d
y
 o
f 
sa
fr
o
le
 u
si
n
g
 a
 m
ed
iu
m
-t
er
m
 
an
im
al
 m
o
d
el
 w
it
h
 g
p
t 
d
el
ta
 r
at
s.
 
T
o
x
ic
o
lo
g
y
 2
9
0
: 
3
1
2
-3
2
1
. 
K
am
ie
n
sk
i,
 F
.X
. 
an
d
 J
.E
. 
C
as
id
a.
 I
m
p
o
rt
an
ce
 o
f 
d
em
et
h
y
le
n
at
io
n
 i
n
 t
h
e 
m
et
ab
o
li
sm
 i
n
 v
iv
o
 a
n
d
 i
n
 v
it
ro
 
o
f 
m
et
h
y
le
n
e-
d
io
x
y
p
h
en
y
l 
sy
n
er
g
is
ts
 a
n
d
 r
el
at
ed
 
co
m
p
o
u
n
d
s 
in
 m
am
m
al
s.
 
B
io
ch
em
ic
al
 P
h
ar
m
ac
o
lo
lg
y
 1
9
: 
9
1
-1
1
2
. 
K
ap
ad
ia
, 
G
. 
J.
, 
E
. 
B
. 
C
h
u
n
g
, 
B
. 
G
h
o
sh
, 
Y
. 
N
. 
S
h
u
k
la
, 
S
. 
P
. 
B
as
ak
, 
J.
 F
. 
M
o
rt
o
n
, 
S
. 
N
. 
P
ra
d
h
an
. 
C
ar
ci
n
o
g
en
ic
it
y
 o
f 
so
m
e 
fo
lk
 m
ed
ic
in
al
 h
er
b
s 
in
 
ra
ts
. 
Jo
u
rn
al
 o
f 
N
at
io
n
al
 C
an
ce
r 
In
st
it
u
te
 6
0
 (
3
):
 6
8
3
-6
8
6
. 
2
0
0
4
 
2
0
1
1
 
1
9
7
0
 
1
9
7
8
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B
. 
su
b
ti
li
s 
w
as
 n
o
t 
in
h
ib
it
ed
 b
y
 
sa
fr
o
le
 o
r 
sa
fr
o
le
 e
p
o
x
id
e,
 b
u
t 
it
 w
as
 
in
h
ib
it
ed
 b
y
 s
af
ro
le
 h
y
d
ro
p
er
o
x
id
e.
 
S
. 
a
u
re
u
s 
w
as
 a
ls
o
 n
o
t 
in
h
ib
it
ed
 b
y
 
sa
fr
o
le
, 
b
u
t 
it
 w
as
 b
y
 s
af
ro
le
 e
p
o
x
id
e 
an
d
 s
af
ro
le
 h
y
d
ro
p
er
o
x
id
e.
 E
. 
co
li
 
w
as
 i
n
h
ib
it
ed
 b
y
 a
ll
 t
h
re
e 
co
m
p
o
u
n
d
s.
  
T
h
e 
p
h
o
to
sy
n
th
es
iz
ed
 c
o
m
p
o
u
n
d
s 
d
er
iv
ed
 f
ro
m
 s
af
ro
le
 i
n
h
ib
it
ed
 
g
ro
w
th
 o
f 
C
a
n
d
id
a
 a
lb
ic
a
n
s.
  
S
af
ro
le
 w
as
 e
ff
ec
ti
v
e 
ag
ai
n
st
 t
h
e 
ri
ce
 
w
ee
v
il
 v
ia
 f
u
m
ig
at
io
n
, 
li
k
el
y
 t
h
ro
u
g
h
 
v
ap
o
r 
ac
ti
o
n
 t
h
ro
u
g
h
 t
h
e 
re
sp
ir
at
o
ry
 
sy
st
em
. 
F
o
u
n
d
 t
h
at
 t
h
e 
es
se
n
ti
al
 o
il
 
d
ir
ec
tl
y
 f
ro
m
 t
h
e 
p
la
n
t 
w
as
 m
o
re
 
ef
fe
ct
iv
e 
th
an
 p
u
ri
fi
ed
 c
o
m
p
o
u
n
d
s,
 
as
 t
h
e 
co
m
p
o
u
n
d
s 
in
 t
h
e 
es
se
n
ti
al
 o
il
 
fr
o
m
 t
h
e 
p
la
n
t 
co
u
ld
 b
e 
ac
ti
n
g
 
sy
n
er
g
is
ti
ca
ll
y
. 
 
    2
5
 
m
ic
ro
g
ra
m
/m
L
 o
f 
es
se
n
ti
al
 
o
il
 o
n
 f
il
te
r 
p
ap
er
 f
o
r 
th
e 
fu
m
ig
an
t 
b
io
as
sa
y
 
S
af
ro
le
 
st
an
d
ar
d
 
S
af
ro
le
 
st
an
d
ar
d
, 
p
h
o
to
sy
n
th
es
iz
ed
 t
o
 
co
m
p
o
u
n
d
 
A
si
a
sa
ru
m
 
si
eb
o
ld
i 
es
se
n
ti
al
 
o
il
 
G
ra
m
-p
o
si
ti
v
e 
b
ac
te
ri
a 
B
a
ci
ll
u
s 
su
b
ti
ll
is
, 
S
ta
p
h
yl
o
co
cc
u
s 
a
u
re
u
s,
 a
n
d
 
g
ra
m
-n
eg
at
iv
e 
b
ac
te
ri
a 
E
. 
co
li
  
C
a
n
d
id
a
 
a
lb
ic
a
n
s,
 f
u
n
g
al
 
p
at
h
o
g
en
 
F
u
m
ig
at
io
n
 
b
io
as
sa
y
 a
g
ai
n
st
 
th
e 
ri
ce
 w
ee
v
il
 
S
it
o
p
h
il
u
s 
o
ry
za
e
 
K
h
ay
y
at
, 
S
. 
A
 a
n
d
 S
. 
H
. 
A
l-
Z
ah
ra
n
i.
 
T
h
er
m
al
, 
p
h
o
to
sy
n
th
es
is
 a
n
d
 
an
ti
b
ac
te
ri
al
 s
tu
d
ie
s 
o
f 
b
io
ac
ti
v
e 
sa
fr
o
le
 d
er
iv
at
iv
e 
as
 p
re
cu
rs
o
r 
fo
r 
n
at
u
ra
l 
fl
av
o
r 
an
d
 f
ra
g
ra
n
ce
. 
A
ra
b
ia
n
 J
o
u
rn
al
 o
f 
C
h
em
is
tr
y
, 
d
o
i:
1
0
.1
0
1
6
/j
.a
ra
b
jc
.2
0
1
1
.0
9
.0
1
4
. 
K
h
ay
y
at
, 
S
. 
A
. 
P
h
o
to
sy
n
th
es
is
 o
f 
d
im
er
ic
 c
in
n
am
al
d
eh
y
d
e,
 e
u
g
en
o
l,
 
an
d
 s
af
ro
le
 a
s 
an
ti
m
ic
ro
b
ia
l 
ag
en
ts
. 
Jo
u
rn
al
 o
f 
S
au
d
i 
C
h
em
ic
al
 S
o
ci
et
y
, 
d
o
i:
 1
0
.1
0
1
6
/j
.j
sc
s.
2
0
1
1
.0
7
.0
1
4
. 
K
im
, 
J.
 a
n
d
 I
-K
. 
P
ar
k
. 
F
u
m
ig
an
t 
to
x
ic
it
y
 o
f 
K
o
re
an
 m
ed
ic
in
al
 p
la
n
t 
es
se
n
ti
al
 o
il
s 
an
d
 c
o
m
p
o
n
en
ts
 f
ro
m
 
A
si
a
sa
ru
m
 s
ie
b
o
ld
i 
ro
o
t 
ag
ai
n
st
 
S
it
o
p
h
il
u
s 
o
ry
za
e 
L
. 
F
la
v
o
u
r 
an
d
 
F
ra
g
ra
n
ce
 J
o
u
rn
al
 2
3
: 
7
9
-8
3
. 
2
0
1
1
 
2
0
1
1
 
2
0
0
8
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In
d
u
ct
io
n
 o
f 
b
en
zo
p
y
re
n
e 
h
y
d
ro
x
y
la
se
, 
w
it
h
 
m
ax
im
u
m
 e
n
zy
m
e 
ac
ti
v
it
y
 w
it
h
in
 1
4
 d
ay
s.
 
In
cr
ea
se
s 
w
h
er
e 
o
b
se
rv
ed
 i
n
 h
ep
at
ic
 b
ip
h
en
y
l 
2
-
h
y
d
ro
x
y
la
se
 a
n
d
 4
-h
y
d
ro
x
y
la
se
 a
ct
iv
it
y
, 
m
ic
ro
so
m
al
 p
ro
te
in
, 
li
v
er
 w
ei
g
h
t,
 c
y
to
ch
ro
m
e 
P
-4
5
0
 c
o
n
te
n
t.
 H
ep
at
ic
 a
n
il
in
e 
4
-h
y
d
ro
x
y
la
se
 
ac
ti
v
it
y
 w
as
 i
n
h
ib
it
ed
. 
 
S
af
ro
le
 i
n
d
u
ce
s 
a 
d
o
se
-d
ep
en
d
en
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o
n
 s
p
ec
tr
u
m
, 
w
h
ic
h
 c
o
u
ld
 r
es
u
lt
 
fr
o
m
 b
io
sy
n
th
es
is
 o
f 
a 
h
ep
at
ic
 
m
ic
ro
so
m
al
 h
ae
m
o
p
ro
te
in
. 
T
h
e 
n
ew
 
ab
so
rp
ti
o
n
 s
p
ec
tr
u
m
 w
as
 n
o
t 
o
b
se
rv
ed
 
w
h
en
 t
h
io
ac
et
am
in
e 
w
as
 a
d
d
ed
 t
o
 t
h
e 
sa
fr
o
le
 i
n
d
u
ct
io
n
. 
 
2
 m
aj
o
r 
ad
d
u
ct
s 
fo
rm
ed
 i
n
 t
h
e 
N
2
 p
o
si
ti
o
n
 
o
f 
g
u
an
in
e 
w
it
h
 s
af
ro
le
 a
n
d
 1
'-
h
y
d
ro
x
y
sa
fr
o
le
 
S
in
g
le
 d
o
se
 
o
f 
7
5
-3
0
0
 
m
g
/k
g
 b
w
 
  1
2
5
 m
g
/k
g
 
p
er
 d
ay
 
  
S
af
ro
le
 
st
an
d
ar
d
 
      
M
al
e 
S
p
ra
g
u
e 
D
aw
le
y
 
ra
ts
 (
2
0
0
-
5
0
0
 g
) 
R
at
 m
o
d
el
 
R
at
 m
o
d
el
 
M
ic
e 
m
o
d
el
 
O
sw
al
d
, 
E
. 
O
.,
 L
. 
F
is
h
b
ei
n
 &
 B
.J
. 
C
o
rb
et
t.
 M
et
ab
o
li
sm
 o
f 
n
at
u
ra
ll
y
 
o
cc
u
rr
in
g
 p
ro
p
en
y
lb
en
ze
n
e 
d
er
iv
at
iv
es
. 
I.
 C
h
ro
m
at
o
g
ra
p
h
ic
 s
ep
ar
at
io
n
 o
f 
n
in
h
y
d
ri
n
-p
o
si
ti
v
e 
m
at
er
ia
ls
 o
f 
ra
t 
u
ri
n
e,
 
Jo
u
rn
al
 o
f 
C
h
ro
m
at
o
g
ra
p
h
y
 4
5
: 
4
3
7
-4
4
5
. 
 
P
ar
k
e,
 D
. 
V
. 
&
 H
. 
R
ah
m
an
. 
T
h
e 
in
d
u
ct
io
n
 o
f 
h
ep
at
ic
 m
ic
ro
so
m
al
 
en
zy
m
es
 b
y
 s
af
ro
le
. 
B
io
ch
em
. 
J.
 1
1
9
: 
5
3
P
. 
P
ar
k
e,
 D
. 
V
. 
&
 H
. 
R
ah
m
an
. 
In
d
u
ct
io
n
 o
f 
a 
n
ew
 h
ep
at
ic
 m
ic
ro
so
m
al
 h
ae
m
o
p
ro
te
in
 
b
y
 s
af
ro
le
 a
n
d
 i
so
sa
fr
o
le
. 
B
io
ch
em
. 
J.
 
1
2
3
: 
9
P
. 
P
h
il
li
p
s,
 D
.,
 M
.V
. 
R
ed
d
y
 a
n
d
 K
. 
R
an
d
er
at
h
. 
3
2
P
- 
P
o
st
la
b
el
li
n
g
 a
n
al
y
si
s 
o
f 
D
N
A
 a
d
d
u
ct
s 
fo
rm
ed
 i
n
 t
h
e 
li
v
er
s 
o
f 
an
im
al
s 
tr
ea
te
d
 w
it
h
 s
af
ro
le
, 
es
tr
ag
o
le
 
an
d
 o
th
er
 n
at
u
ra
ll
y
o
cc
u
ri
n
g
 
al
k
en
y
lb
en
ze
n
es
. 
II
. 
N
ew
b
o
rn
 m
al
e 
B
6
C
3
F
1
 m
ic
e.
 C
ar
ci
n
o
g
en
es
is
 5
: 
1
6
2
3
- 
1
6
2
8
. 
1
9
6
9
 
1
9
7
0
 
1
9
7
1
 
1
9
8
4
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2
 m
in
o
r 
ad
d
u
ct
s 
fo
rm
ed
 i
n
 t
h
e 
N
6
 
p
o
si
ti
o
n
 o
f 
ad
en
in
e 
w
it
h
 s
af
ro
le
 
an
d
 1
'-
h
y
d
ro
x
y
sa
fr
o
le
 
S
af
ro
le
 t
es
te
d
 p
o
si
ti
v
e 
in
 b
o
th
 
S
af
ro
le
 t
es
te
d
 p
o
si
ti
v
e 
fo
r 
th
e 
A
m
es
 t
es
t,
 c
el
l 
tr
an
sf
o
rm
at
io
n
, 
d
eg
ra
n
u
la
ti
o
n
, 
an
d
 s
eb
ac
eo
u
s-
g
la
n
d
 s
u
p
p
re
ss
io
n
 a
n
d
 t
es
te
d
 
n
eg
at
iv
e 
fo
r 
te
tr
az
o
li
u
m
 r
ed
u
ct
io
n
 
an
d
 t
h
e 
im
p
la
n
t 
te
st
s.
  
2
 m
aj
o
r 
ad
d
u
ct
s 
fo
rm
ed
 i
n
 t
h
e 
N
2
 
p
o
si
ti
o
n
 o
f 
g
u
an
in
e 
w
it
h
 s
af
ro
le
 
an
d
 1
'-
h
y
d
ro
x
y
sa
fr
o
le
. 
A
ft
er
 a
 
si
n
g
le
 d
o
se
 o
f 
1
0
 m
g
 o
f 
sa
fr
o
le
, 
o
n
e 
ad
d
u
ct
 f
o
rm
ed
 i
n
 1
4
0
,0
0
0
 
n
u
cl
eo
ti
d
es
. 
R
A
L
 x
 1
0
^
7
 v
al
u
es
 
fo
r 
sa
fr
o
le
 w
er
e 
4
9
1
 +
/-
 1
2
9
 f
o
r 
1
0
 
m
g
 a
n
d
 1
1
4
 +
/-
 5
0
 f
o
r 
th
e 
2
 m
g
 
d
o
se
. 
1
2
 m
ic
ro
m
o
le
s/
 
m
o
u
se
 o
f 
1
'-
[2
',3
'-
3
H
]-
h
y
d
ro
x
y
sa
fr
o
le
 
v
ia
 i
.p
. 
in
je
ct
io
n
. 
   2
 m
g
 f
o
r 
D
N
A
 
b
in
d
in
g
 s
tu
d
ie
s 
o
r 
1
0
 m
g
 f
o
r 
ad
d
u
ct
 
p
er
si
st
en
ce
 
st
u
d
ie
s.
 M
ic
e:
 
8
0
 m
g
/k
g
 o
r 
4
0
0
 m
g
/k
g
. 
  
S
af
ro
le
 
st
an
d
ar
d
 
  S
af
ro
le
 
st
an
d
ar
d
 
S
af
ro
le
 
st
an
d
ar
d
 
F
em
al
e 
C
D
-1
 
m
ic
e,
 8
-1
0
 
w
ee
k
s 
o
ld
 
(3
0
 g
) 
E
. 
co
li
 a
n
d
 
S
a
cc
h
a
ro
m
yc
es
 c
er
ev
is
ia
e 
in
 v
it
ro
 
as
sa
y
s 
A
m
es
 t
es
t 
w
it
h
 
S
a
lm
o
n
el
la
 
ty
p
h
im
u
ri
u
m
; 
R
ab
in
's
 t
es
t 
an
d
 o
th
er
s 
F
em
al
e 
C
D
-1
 
m
ic
e 
(2
5
 g
) 
P
h
il
li
p
s,
 D
.H
.,
 J
.A
. 
M
il
le
r,
 E
.C
. 
M
il
le
r,
 
an
d
 B
. 
A
d
am
s.
 N
2
 a
to
m
 o
f 
g
u
an
in
e 
an
d
 
N
6
 o
f 
ad
en
in
e 
re
si
d
u
es
 a
t 
si
te
s 
fo
r 
co
v
al
en
t 
b
in
d
in
g
 o
f 
m
et
ab
o
li
ca
ll
y
 
ac
ti
v
at
ed
 1
’-
 h
y
d
ro
x
y
sa
fr
o
le
 t
o
 m
o
u
se
 
li
v
er
 D
N
A
 i
n
 v
iv
o
. 
C
an
ce
r 
R
es
. 
4
1
: 
2
6
2
4
-2
6
7
1
. 
P
o
ir
ie
r,
 L
.A
. 
an
d
 F
. 
J.
 d
e 
S
er
re
s.
 I
n
it
ia
l 
N
at
io
n
al
 C
an
ce
r 
In
st
it
u
te
 s
tu
d
ie
s 
o
n
 
m
u
ta
g
en
es
is
 a
s 
a 
p
re
-s
cr
ee
n
 f
o
r 
ch
em
ic
al
 c
ar
ci
n
o
g
en
s:
 a
n
 a
p
p
ra
is
al
. 
J.
 
N
at
l.
 C
an
ce
r 
In
st
. 
6
2
: 
9
1
9
-9
2
6
. 
P
u
rc
h
as
e,
 I
. 
F
. 
H
. 
et
 a
l.
 A
n
 e
v
al
u
at
io
n
 
o
f 
6
 s
h
o
rt
-t
er
m
 t
es
ts
 f
o
r 
d
et
ec
ti
n
g
 
o
rg
an
ic
 c
h
em
ic
al
 c
ar
ci
n
o
g
en
s,
 B
r.
 J
. 
C
an
ce
r 
3
7
: 
8
7
3
-9
0
3
. 
R
an
d
er
at
h
, 
K
.,
 R
.E
. 
H
ag
lu
n
d
, 
D
.H
. 
P
h
il
li
p
s 
an
d
 M
.V
. 
R
ed
d
y
. 
3
2
P
- 
P
o
st
la
b
el
li
n
g
 a
n
al
y
si
s 
o
f 
D
N
A
 a
d
d
u
ct
s 
fo
rm
ed
 i
n
 t
h
e 
li
v
er
s 
o
f 
an
im
al
s 
tr
ea
te
d
 
w
it
h
 s
af
ro
le
, 
es
tr
ag
o
le
 a
n
d
 o
th
er
 
n
at
u
ra
ll
y
-o
cc
u
rr
in
g
 a
lk
en
y
lb
en
ze
n
es
. 
I.
 
A
d
u
lt
 f
em
al
e 
C
D
-1
 m
ic
e.
 
C
ar
ci
n
o
g
en
es
is
 5
: 
1
6
1
3
-1
6
2
2
. 
1
9
8
1
 
1
9
7
9
 
1
9
7
8
 
1
9
8
4
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M
ic
e 
th
at
 o
n
ly
 d
ra
n
k
 c
o
la
-d
ri
n
k
s 
d
ev
el
o
p
ed
 1
0
0
-2
0
0
 D
N
A
 a
d
d
u
ct
s 
in
 1
0
^
9
 
D
N
A
 n
u
cl
eo
ti
d
es
, 
w
it
h
 s
af
ro
le
 5
-6
%
 o
f 
th
e 
ad
d
u
ct
s 
an
d
 m
y
ri
st
ic
in
 5
0
-8
0
%
. 
A
t 
 8
 
w
ee
k
s,
 s
af
ro
le
  
re
p
re
se
n
te
d
 5
-6
%
 o
f 
th
e 
to
ta
l 
ad
d
u
ct
s.
 F
o
r 
 m
y
ri
st
ic
in
, 
n
u
tm
eg
, 
an
d
 m
ac
e,
 s
af
ro
le
 a
d
d
u
ct
s 
re
p
re
se
n
te
d
 
3
.5
-8
.5
%
 o
f 
th
e 
to
ta
l 
ad
d
u
ct
s.
  
D
ih
y
d
ro
sa
fr
o
le
 i
n
je
st
io
n
 r
es
u
lt
ed
 i
n
 
n
eo
p
la
sm
s 
o
f 
th
e 
fo
re
st
o
m
ac
h
. 
S
af
ro
le
 
an
d
 i
so
sa
fr
o
le
 d
id
 n
o
t 
h
av
e 
st
o
m
ac
h
 
tu
m
o
rs
, 
b
u
t 
sa
fr
o
le
 d
id
 i
n
cr
ea
se
 t
h
e 
in
ci
d
en
ce
s 
o
f 
li
v
er
 c
ar
ci
n
o
m
as
. 
A
 d
o
se
 o
f 
2
0
 m
g
/k
g
 o
f 
sa
fr
o
le
 d
o
u
b
le
d
 t
h
e 
m
ea
n
 s
le
ep
in
g
 t
im
e 
co
m
p
ar
ed
 t
o
 t
h
e 
co
n
tr
o
l 
w
h
en
 a
d
d
ed
 t
o
 t
h
e 
sl
ee
p
in
g
 t
ab
le
t 
co
m
p
o
u
n
d
 s
o
d
iu
m
 p
en
to
b
ar
b
it
al
. 
S
af
ro
le
 
d
id
 n
o
t 
si
g
n
if
ic
an
tl
y
 a
ff
ec
t 
th
e 
sl
ee
p
in
g
 
ti
m
e 
in
 a
ss
o
ci
at
io
n
 w
it
h
 e
th
an
o
l.
  
In
 t
h
e 
m
ic
e 
th
at
 r
ec
ei
v
ed
 4
.5
0
 g
/k
g
 b
w
, 
1
0
 
o
u
t 
o
f 
3
0
 d
ie
d
 a
n
d
 t
h
re
e 
m
ic
e 
h
ad
 l
u
n
g
 
tu
m
o
rs
. 
T
h
e 
m
ic
e 
th
e 
re
ce
iv
ed
 0
.9
0
 g
/k
g
 
b
w
, 
3
 o
u
t 
o
f 
3
0
 d
ie
d
 a
n
d
 6
 m
ic
e 
h
ad
 l
u
n
g
 
tu
m
o
rs
. 
 
M
ic
e 
:c
o
la
 d
ri
n
k
s 
in
st
ea
d
 o
f 
w
at
er
 (
fo
r 
4
 o
r 
8
 w
ee
k
s)
, 
m
ic
e 
g
iv
en
 a
 s
in
g
le
 1
0
 m
g
 
d
o
se
 o
f 
m
y
ri
st
ic
in
, 
n
u
tm
eg
, 
o
r 
m
ac
e 
v
ia
 
g
as
tr
ic
 i
n
tu
b
at
io
n
. 
 
4
6
4
 m
g
/k
g
 o
f 
sa
fr
o
le
 
&
 d
ih
y
d
ro
sa
fr
o
le
: 
2
1
5
 m
g
/k
g
 o
f 
is
o
sa
fr
o
le
; 
1
,1
1
2
 
p
p
m
 s
af
ro
le
, 
1
,4
0
0
 
p
p
m
 d
ih
y
d
ro
sa
fr
o
le
, 
&
 5
1
7
 p
p
m
 
is
o
sa
fr
o
le
. 
 
1
0
 o
r 
2
0
 m
g
/k
g
 v
ia
 
i.
p
. 
in
je
ct
io
n
 a
lo
n
g
 
w
it
h
 s
o
d
iu
m
 
p
en
to
b
ar
b
it
al
 a
n
d
 
1
0
0
 m
g
/k
g
 v
ia
 i
.p
. 
in
je
ct
io
n
 o
f 
et
h
an
o
l 
O
v
er
 2
4
 w
ee
k
s,
 
m
ic
e 
re
ce
iv
ed
 a
 t
o
ta
l 
o
f 
4
.5
0
 o
r 
0
.9
0
 g
/k
g
 
b
w
 o
f 
sa
fr
o
le
 o
v
er
 
1
2
 i
n
je
ct
io
n
s.
  
S
af
ro
le
 
S
ta
n
d
ar
d
 
S
af
ro
le
 
st
an
d
ar
d
 
S
af
ro
le
 
st
an
d
ar
d
 
S
af
ro
le
 
st
an
d
ar
d
 
F
em
al
e 
IC
R
 
m
ic
e,
 6
-7
 
w
ee
k
s 
H
y
b
ri
d
 
m
ic
e
 
F
em
al
e 
w
h
it
e 
m
ic
e 
(2
2
-4
0
 g
) 
A
/H
e 
m
ic
e,
 6
-8
 
w
ee
k
s 
o
ld
 (
1
8
-
2
0
 g
) 
R
an
d
er
at
h
, 
K
.P
.,
 K
.L
. 
P
u
tm
an
, 
an
d
 E
. 
R
an
d
er
at
h
. 
F
la
v
o
r 
co
n
st
it
u
en
ts
 i
n
 c
o
la
 d
ri
n
k
s 
in
d
u
ce
 h
ep
at
ic
 D
N
A
 a
d
d
u
ct
s 
in
 
ad
u
lt
 a
n
d
 f
et
al
 m
ic
e.
 
B
io
ch
em
ic
al
 B
io
p
h
y
si
ca
l 
R
es
ea
rc
h
 C
o
m
m
u
n
ic
at
io
n
s 
1
9
2
 
(1
):
 6
1
-6
8
. 
R
eu
b
er
, 
M
. 
D
. 
N
eo
p
la
sm
s 
o
f 
th
e 
fo
re
st
o
m
ac
h
 i
n
 m
ic
e 
in
g
es
ti
n
g
 
d
ih
y
d
ro
sa
fr
o
le
, 
D
ig
es
ti
o
n
, 
1
9
, 
4
2
-4
7
 
S
et
o
, 
T
. 
A
. 
&
 W
. 
K
eu
p
. 
E
ff
ec
ts
 
o
f 
al
k
y
lm
et
h
o
x
y
b
en
ze
n
e 
an
d
 
al
k
y
lm
et
h
y
le
n
ed
io
x
y
b
en
ze
n
e 
es
se
n
ti
al
 o
il
s 
o
n
 p
en
to
b
ar
b
it
al
 
an
d
 e
th
an
o
l 
sl
ee
p
in
g
 t
im
e.
 A
rc
h
 
In
te
rn
d
e 
P
h
ar
m
ac
o
d
y
n
am
ie
 e
t 
d
e 
th
er
ap
ie
 1
8
0
: 
2
3
2
-2
4
0
. 
 
S
to
n
er
, 
G
. 
D
. 
et
 a
l.
 T
es
t 
fo
r 
ca
rc
in
o
g
en
ic
it
y
 o
f 
fo
o
d
 a
d
d
it
iv
es
 
an
d
 c
h
em
o
th
er
ap
eu
ti
c 
ag
en
ts
 b
y
 
th
e 
p
u
lm
o
n
ar
y
 t
u
m
o
r 
re
sp
o
n
se
 i
n
 
st
ra
in
 A
 m
ic
e,
 C
an
ce
r 
R
es
ea
rc
h
 
3
3
: 
3
0
6
9
-3
0
8
5
. 
1
9
9
3
 
1
9
7
9
 
1
9
6
9
 
1
9
7
3
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S
af
ro
le
 w
as
 n
eu
tr
al
 o
r 
w
ea
k
ly
 p
o
si
ti
v
e 
in
 
th
e 
A
m
es
 t
es
t.
 1
'-
h
y
d
ro
x
y
sa
fr
o
le
 w
as
 
m
u
ta
g
en
ic
 f
o
r 
st
ra
in
 T
A
1
0
0
. 
T
o
x
ic
it
y
 
in
cr
ea
se
d
 w
it
h
 a
d
d
it
io
n
 o
f 
N
A
D
P
H
-
fo
rt
if
ie
d
 r
at
 l
iv
er
 m
ic
ro
so
m
es
 a
n
d
 
cy
to
so
l.
 P
re
v
io
u
s 
st
u
d
ie
s 
w
it
h
 p
o
si
ti
v
e 
m
u
ta
g
en
ic
 p
ro
p
er
ti
es
 u
se
d
 a
 
p
re
in
cu
b
at
io
n
 p
er
io
d
, 
w
h
ic
h
 m
ay
b
e 
h
av
e 
cr
ea
te
d
 m
et
ab
o
li
te
s.
  
N
o
 r
at
s 
d
ie
d
 o
u
t 
o
f 
si
x
 t
es
te
d
 f
o
r 
sa
fr
o
le
, 
b
u
t 
an
 a
v
er
ag
e 
o
f 
2
.5
 m
ac
ro
sc
o
p
ic
 l
iv
er
 
le
si
o
n
s 
w
er
e 
o
b
se
rv
ed
. 
T
h
e 
ra
ts
 l
o
st
 
w
ei
g
h
t 
an
d
 w
er
e 
in
 p
o
o
r 
co
n
d
it
io
n
 a
t 
th
e 
en
d
 o
f 
th
e 
ex
p
er
im
en
t.
  
S
af
ro
le
 i
n
h
ib
it
s 
C
Y
P
1
A
2
, 
C
Y
P
2
A
6
, 
C
Y
P
2
D
6
, 
C
Y
P
2
E
1
, 
an
d
 C
Y
P
3
A
4
 
S
af
ro
le
 a
n
d
/o
r 
m
et
ab
o
li
te
s 
cr
o
ss
ed
 t
h
e 
p
la
ce
n
ta
 a
n
d
 w
as
 d
el
iv
er
ed
 t
o
 i
n
fa
n
ts
 v
ia
 
la
ct
at
io
n
, 
b
u
t 
y
o
u
n
g
 m
ic
e 
h
ad
 h
ad
 m
u
ch
 
h
ig
h
er
 s
u
rv
iv
al
 r
at
e 
(>
9
0
%
) 
w
h
en
 i
n
 
u
te
ro
 a
n
d
 n
u
rs
in
g
 f
ro
m
 m
o
th
er
s 
re
ce
iv
in
g
 s
af
ro
le
 c
o
m
p
ar
ed
 t
o
 w
ea
n
ed
 
ra
ts
 t
h
at
 r
ec
ei
v
ed
 d
ir
ec
t 
sa
fr
o
le
 d
o
se
s.
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Table C.3: Review of studies using chemical analysis of foods containing safrole. 
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Appendix D 
Abbreviations 
Abbreviation  Meaning 
 
Bw    Body Weight 
CCP   Center for Cherokee Plants 
CDC   Center for Disease Control and Prevention 
CFR    Code of Federal Regulations 
EBCI   Eastern Band of Cherokee Indians 
FDA   Food and Drug Administration 
GIS   Geographic Information System 
HPLC   High Performance-Liquid Chromatography 
MCI    Museum of the Cherokee Indian 
mg/kg bw  milligram/kilogram of body weight 
ppm   Parts Per Million 
SCF   Scientific Committee on Food (European Commission)   
WHO   World Health Organization 
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